<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1133" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1133/" /><meta name="ncbi_pagename" content="Loeys-Dietz Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Loeys-Dietz Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Loeys-Dietz Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2018/03/01" /><meta name="citation_author" content="Bart L Loeys" /><meta name="citation_author" content="Harry C Dietz" /><meta name="citation_pmid" content="20301312" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1133/" /><meta name="citation_keywords" content="Loeys-Dietz Aortic Aneurysm Syndrome" /><meta name="citation_keywords" content="Loeys-Dietz Aortic Aneurysm Syndrome" /><meta name="citation_keywords" content="Mothers against decapentaplegic homolog 2" /><meta name="citation_keywords" content="Mothers against decapentaplegic homolog 3" /><meta name="citation_keywords" content="TGF-beta receptor type-1" /><meta name="citation_keywords" content="TGF-beta receptor type-2" /><meta name="citation_keywords" content="Transforming growth factor beta-2 proprotein" /><meta name="citation_keywords" content="Transforming growth factor beta-3 proprotein" /><meta name="citation_keywords" content="SMAD2" /><meta name="citation_keywords" content="SMAD3" /><meta name="citation_keywords" content="TGFB2" /><meta name="citation_keywords" content="TGFB3" /><meta name="citation_keywords" content="TGFBR1" /><meta name="citation_keywords" content="TGFBR2" /><meta name="citation_keywords" content="Loeys-Dietz Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Loeys-Dietz Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Bart L Loeys" /><meta name="DC.Contributor" content="Harry C Dietz" /><meta name="DC.Date" content="2018/03/01" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1133/" /><meta name="description" content="Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant." /><meta name="og:title" content="Loeys-Dietz Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among affected individuals within a family who have the same pathogenic variant." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1133/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/loeys-dietz/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1133/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C1179E0407E51000000000316010C.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1133_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1133_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lipoid-p/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rws/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1133_"><span class="title" itemprop="name">Loeys-Dietz Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Loeys-Dietz Aortic Aneurysm Syndrome</div><p class="contrib-group"><span itemprop="author">Bart L Loeys</span>, MD, PhD and <span itemprop="author">Harry C Dietz</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1133_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1133_ai__"><div class="contrib half_rhythm"><span itemprop="author">Bart L Loeys</span>, MD, PhD<div class="affiliation small">Center Medical Genetics <br />Antwerp University Hospital<br />Antwerp, Belgium<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="eb.prewtnau@syeol.trab" class="oemail">eb.prewtnau@syeol.trab</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Harry C Dietz</span>, MD<div class="affiliation small">Victor A McKusick Professor of Medicine and Genetics, Institute of Genetic Medicine<br />Howard Hughes Medical Institute <br />Departments of Pediatrics, Medicine, and Molecular Biology and Genetics <br />Johns Hopkins University School of Medicine <br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.imhj@zteidh" class="oemail">ude.imhj@zteidh</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">February 28, 2008</span>; Last Update: <span itemprop="dateModified">March 1, 2018</span>.</p><p><em>Estimated reading time: 42 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="loeys-dietz.Summary" itemprop="description"><h2 id="_loeys-dietz_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Loeys-Dietz syndrome (LDS) is characterized by vascular findings (cerebral, thoracic, and abdominal arterial aneurysms and/or dissections), skeletal manifestations (pectus excavatum or pectus carinatum, scoliosis, joint laxity, arachnodactyly, talipes equinovarus, cervical spine malformation and/or instability), craniofacial features (widely spaced eyes, strabismus, bifid uvula / cleft palate, and craniosynostosis that can involve any sutures), and cutaneous findings (velvety and translucent skin, easy bruising, and dystrophic scars). Individuals with LDS are predisposed to widespread and aggressive arterial aneurysms and pregnancy-related complications including uterine rupture and death. Individuals with LDS can show a strong predisposition for allergic/inflammatory disease including asthma, eczema, and reactions to food or environmental allergens. There is also an increased incidence of gastrointestinal inflammation including eosinophilic esophagitis and gastritis or inflammatory bowel disease. Wide variation in the distribution and severity of clinical features can be seen in individuals with LDS, even among <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals within a family who have the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of LDS is established in individuals based on characteristic clinical findings in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> and family members and/or by the identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>, <i>TGFBR1</i>, or <i>TGFBR2</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Important considerations when managing cardiovascular features of LDS: aortic dissection can occur at smaller aortic diameters and at younger ages than observed in Marfan syndrome; vascular disease is not limited to the aortic root; angiotensin receptor blockers, beta-adrenergic receptor blockers, or other medications are used to reduce hemodynamic stress; and aneurysms are amenable to early and aggressive surgical intervention. Surgical fixation of cervical spine instability may be necessary to prevent spinal cord damage. Treatment is standard for clubfeet and severe <i>pes planus</i>. Management by a craniofacial team is preferred for treatment of cleft palate and craniosynostosis. Standard treatment for allergic complications with consideration of referral to an allergy/immunology specialist in severe cases. Careful and aggressive refraction and visual correction is mandatory in young children at risk for amblyopia. Hernias tend to recur after surgical intervention. A supporting mesh can be used during surgical repair to minimize <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>. Optimal management of pneumothorax to prevent recurrence may require chemical or surgical pleurodesis or surgical removal of pulmonary blebs.</p><p><i>Prevention of secondary complications:</i> Consider subacute bacterial endocarditis (SBE) prophylaxis in those undergoing dental work or other procedures expected to contaminate the bloodstream with bacteria. Because of high risk for cervical spine instability, a flexion/extension x-ray of the cervical spine should be performed prior to intubation or any other procedure involving manipulation of the neck.</p><p><i>Surveillance:</i> All individuals with LDS require echocardiography at frequent intervals to monitor the status of the ascending aorta; the frequency of magnetic resonance angiography (MRA) or computerized tomography angiography (CTA) evaluation to image the entire arterial tree depends on clinical findings. Individuals with cervical spine instability and severe or progressive scoliosis should be followed by an orthopedist.</p><p><i>Agents/circumstances to avoid:</i> Contact sports, competitive sports, and isometric exercise; agents that stimulate the cardiovascular system including routine use of decongestants or triptan medications for the management of migraine headache; activities that cause joint injury or pain; for individuals at risk for recurrent pneumothorax, breathing against a resistance (e.g., playing a brass instrument) or positive pressure ventilation (e.g., SCUBA diving).</p><p><i>Evaluation of relatives at risk:</i> If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can be used to clarify genetic status of at-risk family members; if the pathogenic variant is not known, relatives at risk should be evaluated for signs of LDS, including echocardiography and extensive vascular imaging if findings suggest LDS or if findings were subtle in the index case.</p><p><i>Pregnancy management</i>: Pregnancy and the postpartum period can be dangerous for women with LDS because of increased risk of aortic dissection/rupture and uterine rupture. Increased frequency of aortic imaging is recommended, both during pregnancy and in the weeks following delivery.</p><p><i>Therapies under investigation:</i> The safety and efficacy of angiotensin II receptor type 1 blockers (ARBs) has not been addressed for persons with LDS in a clinical trial setting, but ARBs have proven safe and comparable or superior to beta blockers in treating other vascular connective tissue disorders, such as Marfan syndrome.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>LDS is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Approximately 25% of individuals diagnosed with LDS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; approximately 75% of probands have LDS as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Each child of an individual with LDS has a 50% chance of inheriting the pathogenic variant and the disorder. Prenatal diagnosis for pregnancies at increased risk for LDS is possible if the pathogenic variant in the family is known.</p></div></div><div id="loeys-dietz.Diagnosis"><h2 id="_loeys-dietz_Diagnosis_">Diagnosis</h2><p>While various clinical presentations have in the past been labeled as LDS type I (craniofacial features present), LDS type II (minimal to absent craniofacial features), and LDS type III (presence of osteoarthritis) (see <a href="#loeys-dietz.Phenotype_Correlations_by_Ge">Phenotype Correlations by Gene</a>), it is now recognized that LDS caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in any of the six known genes (see <a class="figpopup" href="/books/NBK1133/table/loeys-dietz.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figloeysdietzTmoleculargenetictesting" rid-ob="figobloeysdietzTmoleculargenetictesting">Table 1</a>) is a continuum in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have various combinations of clinical features.</p><div id="loeys-dietz.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Loeys-Dietz syndrome (LDS) <b>should be suspected</b> in individuals with the following vascular, skeletal, craniofacial, cutaneous, allergic/inflammatory, and ocular findings [<a class="bk_pop" href="#loeys-dietz.REF.loeys.2005.275">Loeys et al 2005</a>].</p><p><b>Vascular</b></p><ul><li class="half_rhythm"><div><b>Dilatation or dissection of the aorta and other arteries.</b> Aortic root dilatation is seen in more than 95% of probands; the aortic root is the most common site for a dissection to occur. In rare circumstances, aneurysms or dissections can be seen in other arteries in the head, chest, abdomen, or extremities in the absence of aortic involvement.</div></li><li class="half_rhythm"><div><b>Other arterial aneurysms and tortuosity</b></div><ul><li class="half_rhythm"><div>Evaluation is best done with magnetic resonance angiography (MRA) or CT angiogram (CTA) with 3D reconstruction from head to pelvis to identify arterial aneurysms or dissections and arterial tortuosity throughout the arterial tree.</div></li><li class="half_rhythm"><div>Tortuosity is often most prominent in head and neck vessels.</div></li><li class="half_rhythm"><div>Approximately 50% of individuals with LDS studied had an aneurysm distant from the aortic root that would not have been detected by echocardiography.</div></li></ul></li></ul><p><b>Skeletal</b></p><ul><li class="half_rhythm"><div>Pectus excavatum or pectus carinatum</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Joint laxity or contracture (typically involving the fingers)</div></li><li class="half_rhythm"><div>Arachnodactyly</div></li><li class="half_rhythm"><div>Talipes equinovarus</div></li><li class="half_rhythm"><div>Cervical spine malformation and/or instability</div></li><li class="half_rhythm"><div>Osteoarthritis</div></li></ul><p><b>Craniofacial</b></p><ul><li class="half_rhythm"><div>Widely spaced eyes</div></li><li class="half_rhythm"><div>Bifid uvula / cleft palate</div></li><li class="half_rhythm"><div>Craniosynostosis, in which any sutures can be involved</div></li></ul><p><b>Cutaneous</b></p><ul><li class="half_rhythm"><div>Soft and velvety skin</div></li><li class="half_rhythm"><div>Translucent skin with easily visible underlying veins</div></li><li class="half_rhythm"><div>Easy bruising</div></li><li class="half_rhythm"><div>Dystrophic scars</div></li><li class="half_rhythm"><div>Milia, prominently on the face</div></li></ul><p><b>Allergic/inflammatory disease</b></p><ul><li class="half_rhythm"><div>Food allergies</div></li><li class="half_rhythm"><div>Seasonal allergies</div></li><li class="half_rhythm"><div>Asthma / chronic sinusitis</div></li><li class="half_rhythm"><div>Eczema</div></li><li class="half_rhythm"><div>Eosinophilic esophagitis/gastritis</div></li><li class="half_rhythm"><div>Inflammatory bowel disease</div></li></ul><p><b>Ocular.</b> Blue or dusky sclerae</p></div><div id="loeys-dietz.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of Loeys-Dietz syndrome <b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> (by definition a person without a known family history of LDS) who has a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>, <i>TGFBR1</i>, or <i>TGFBR2</i> (see <a class="figpopup" href="/books/NBK1133/table/loeys-dietz.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figloeysdietzTmoleculargenetictesting" rid-ob="figobloeysdietzTmoleculargenetictesting">Table 1</a>) and EITHER of the following [<a class="bk_pop" href="#loeys-dietz.REF.maccarrick.2014">MacCarrick et al 2014</a>]:</p><ul><li class="half_rhythm"><div>Aortic root enlargement (defined as an aortic root z-score &#x02265;2.0) or type A dissection</div></li><li class="half_rhythm"><div>Compatible systemic features including characteristic craniofacial, skeletal, cutaneous, and/or vascular manifestations found in combination. Special emphasis is given to arterial tortuosity, prominently including the head and neck vessels, and to aneurysms or dissections involving medium-to-large muscular arteries throughout the arterial tree.</div></li></ul><p>Note: In the presence of a family history of documented LDS, the diagnosis can be made in at-risk relatives on the basis of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> even if vascular involvement or other features are not yet apparent (see <a href="#loeys-dietz.Evaluation_of_Relatives_at_R">Evaluation of Relatives at Risk</a>).</p><p><b>Molecular genetic testing approaches</b> can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (serial single-gene testing or a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (comprehensive genomic sequencing) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because of clinical overlap, it is difficult to predict which of the known LDS-related genes will be causative in any given <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual. Although individuals with the distinctive findings of LDS described in <a href="#loeys-dietz.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#loeys-dietz.Option_1">Option 1</a>), those who do not have sufficiently discriminating features to consider the diagnosis of LDS are more likely to be diagnosed using genomic testing (see <a href="#loeys-dietz.Option_2">Option 2</a>).</p><div id="loeys-dietz.Option_1"><h4>Option 1</h4><p>When the clinical findings suggest the diagnosis of LDS, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>.</p><p><b>Serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Sequence analysis of the genes listed in <a class="figpopup" href="/books/NBK1133/table/loeys-dietz.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figloeysdietzTmoleculargenetictesting" rid-ob="figobloeysdietzTmoleculargenetictesting">Table 1</a> can be performed first, typically in order of descending frequency (i.e., <i>TGFBR2</i>, <i>TGFBR1</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>SMAD2</i>, and <i>TGFB3</i>). Gene targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> for <i>SMAD3</i>, <i>TGFB2</i>, and <i>TGFB3</i> should be considered upon strong clinical suspicion and normal <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p><ul><li class="half_rhythm"><div>Sequencing of <i>SMAD3</i> could be considered first if early osteoarthritis is evident in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> or family.</div></li><li class="half_rhythm"><div><i>TGFB2</i> or <i>TGFB3</i> can be analyzed first in individuals with milder phenotypes.</div></li></ul><p><b>A multigene Marfan syndrome / Loeys-Dietz syndrome / <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> thoracic aortic aneurysms and dissections panel</b> that includes <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>,<i>TGFBR1</i>, and <i>TGFBR2</i> as well as a number of other genes associated with disorders that include aortic aneurysms and dissections (see <a href="#loeys-dietz.Differential_Diagnosis">Differential Diagnosis</a>) may be offered by clinical laboratories. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests. For LDS a multigene panel that also includes deletion/duplication analysis may be considered (see <a class="figpopup" href="/books/NBK1133/table/loeys-dietz.T.molecular_genetic_testing/?report=objectonly" target="object" rid-figpopup="figloeysdietzTmoleculargenetictesting" rid-ob="figobloeysdietzTmoleculargenetictesting">Table 1</a>).</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div><div id="loeys-dietz.Option_2"><h4>Option 2</h4><p>When the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is indistinguishable from other inherited disorders with features observed in LDS syndrome, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>).</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="loeys-dietz.T.molecular_genetic_testing" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in Loeys-Dietz Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.T.molecular_genetic_testing/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.T.molecular_genetic_testing_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" style="text-align:left;vertical-align:middle;">Proportion of LDS Attributed to Pathogenic Variants in This Gene&#x000a0;<sup>2</sup></th><th id="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Pathogenic Variants&#x000a0;<sup>3</sup> Detected by Test Method</th></tr><tr><th headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3" id="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>4</sup></th><th headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3" id="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></th></tr></thead><tbody><tr><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMAD2</i></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~1%-5%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMAD3</i></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%-10%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>7</sup></td></tr><tr><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFB2</i></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~5%-10%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>8</sup></td></tr><tr><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFB3</i></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~1%-5%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">90%-95%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Rare&#x000a0;<sup>9</sup></td></tr><tr><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFBR1</i></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~20%-25%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 10</td></tr><tr><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFBR2</i></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~55%-60%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 10</td></tr><tr><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown&#x000a0;<sup>11</sup></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_1_3 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_1 hd_h_loeys-dietz.T.molecular_genetic_testing_1_1_2_2" colspan="2" rowspan="1" style="text-align:left;vertical-align:middle;">NA</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="loeys-dietz.TF.1.1"><p class="no_margin">See <a href="/books/NBK1133/#loeys-dietz.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="loeys-dietz.TF.1.2"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.meester.2017.582">Meester et al [2017]</a></p></div></dd><dt>3. </dt><dd><div id="loeys-dietz.TF.1.3"><p class="no_margin">See <a href="#loeys-dietz.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>4. </dt><dd><div id="loeys-dietz.TF.1.4"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>5. </dt><dd><div id="loeys-dietz.TF.1.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods that may be used include: <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="loeys-dietz.TF.1.6"><p class="no_margin">No data on <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted del/dup analysis are available.</p></div></dd><dt>7. </dt><dd><div id="loeys-dietz.TF.1.7"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.hilhorsthofstee.2013.337">Hilhorst-Hofstee et al [2013]</a></p></div></dd><dt>8. </dt><dd><div id="loeys-dietz.TF.1.8"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.lindsay.2012.922">Lindsay et al [2012]</a>, <a class="bk_pop" href="#loeys-dietz.REF.gaspar.2017.2289">Gaspar et al [2017]</a></p></div></dd><dt>9. </dt><dd><div id="loeys-dietz.TF.1.9"><p class="no_margin">Deletion of <i>TGFB3</i> has been observed [Author, personal communication].</p></div></dd><dt>10. </dt><dd><div id="loeys-dietz.TF.1.10"><p class="no_margin">Whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of <i>TGFBR2</i> [<a class="bk_pop" href="#loeys-dietz.REF.campbell.2011.1442">Campbell et al 2011</a>] or <i>TGFBR1</i> [<a class="bk_pop" href="#loeys-dietz.REF.redon.2006.759">Redon et al 2006</a>] and <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of a 14.6-Mb region surrounding <i>TGFBR1</i> [<a class="bk_pop" href="#loeys-dietz.REF.breckpot.2010.408">Breckpot et al 2010</a>] have been reported; however, these individuals lacked aortic involvement. Several other persons with deletions of <i>TGFBR1</i> or <i>TGFBR2</i> have not developed aortic aneurysms to date, suggesting that at least some mutated protein needs to be present [<a class="bk_pop" href="#loeys-dietz.REF.lindsay.2011.308">Lindsay &#x00026; Dietz 2011</a>]. As such, whole deletion/duplication of <i>TGFBR1</i> or <i>TGFBR2</i> do not present with clear features of Loeys-Dietz syndrome. Smaller deletions/duplications that lead to in frame events are likely to cause an LDS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, whereas events leading to out of frame are not.</p></div></dd><dt>11. </dt><dd><div id="loeys-dietz.TF.1.11"><p class="no_margin">Based on rare individuals with discriminating features of LDS who show no pathogenic variants in the known genes, additional LDS-associated genes remain to be identified [Authors, personal observation].</p></div></dd></dl></div></div></div></div></div></div><div id="loeys-dietz.Clinical_Characteristics"><h2 id="_loeys-dietz_Clinical_Characteristics_">Clinical Characteristics</h2><div id="loeys-dietz.Clinical_Description"><h3>Clinical Description</h3><p>Loeys-Dietz syndrome represents a wide phenotypic spectrum in which <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals may have various combinations of clinical features ranging from a severe <a class="def" href="/books/n/gene/glossary/def-item/syndromic/">syndromic</a> presentation with significant extravascular systemic findings in young children to predominantly thoracic aortic aneurysm/dissection occurring in adults. Clinical variability is also observed among individuals in the same family who have the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. The most common findings involve the vascular, skeletal, craniofacial, cutaneous, allergic/inflammatory, and ocular systems [<a class="bk_pop" href="#loeys-dietz.REF.loeys.2005.275">Loeys et al 2005</a>, <a class="bk_pop" href="#loeys-dietz.REF.loeys.2006.788">Loeys et al 2006</a>].</p><div id="loeys-dietz.Cardiovascular"><h4>Cardiovascular</h4><p>The major sources of morbidity and early mortality in LDS are dilatation of the aorta at the level of the sinuses of Valsalva, a predisposition for aortic dissection and rupture, mitral valve prolapse (MVP) with or without regurgitation, and enlargement of the proximal pulmonary artery.</p><p>Individuals with LDS have a more aggressive vascular course (with routine involvement of vascular segments distant from the aortic root) than that observed in <a href="/books/n/gene/marfan/">Marfan syndrome</a>. Mean age at death is 26 years [<a class="bk_pop" href="#loeys-dietz.REF.loeys.2006.788">Loeys et al 2006</a>]. <a class="bk_pop" href="#loeys-dietz.REF.attias.2009.2541">Attias et al [2009]</a> reported that the proportion of individuals with aortic dilatation, the age at dissection, and the need for surgery were similar in those with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <i>TGFBR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> and those with a heterozygous <i>FBN1</i> pathogenic variant causative of Marfan syndrome; however, the rate of death was greater in families with a heterozygous <i>TGFBR2</i> pathogenic variant. Similarly, a study of 228 families with a heterozygous pathogenic variant in either <i>TGFBR1</i> or <i>TGFBR2</i> demonstrated similar aortic risk (dissection or aortic surgery) in both groups [<a class="bk_pop" href="#loeys-dietz.REF.jondeau.2016.548">Jondeau et al 2016</a>].</p><p><b>Arterial aneurysms</b> have been observed in almost all side branches of the aorta including (but not limited to) the subclavian, renal, superior mesenteric, hepatic, and coronary arteries.</p><p><b>Aortic dissection</b> has been observed in early childhood (age &#x02265;6 months) and/or at aortic dimensions that do not confer risk in other connective tissue disorders such as Marfan syndrome.</p><p><b>Arterial tortuosity</b> can be generalized but most commonly involves the head and neck vessels:</p><ul><li class="half_rhythm"><div>The arterial involvement is widespread, and arterial tortuosity is present in a majority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have multiple arterial anomalies.</div></li><li class="half_rhythm"><div>Vertebral and carotid artery dissection and cerebral bleeding have been described; however, <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> carotid artery dissection in the absence of aortic root involvement has not been observed.</div></li></ul><p><b>MVP</b> with mitral regurgitation has been observed in individuals with LDS, although less frequently than in Marfan syndrome.</p><p><b>Other</b> recurrent cardiovascular findings include patent ductus arteriosus, atrial septal defects, and bicuspid aortic valve. Although all of these findings are common in individuals who do not have LDS, the incidence in LDS exceeds by at least five times that seen in the general population.</p><p><b>Aortic histopathology.</b> Histologic examination of aortic tissue reveals fragmentation of elastic fibers, loss of elastin content, and accumulation of amorphous matrix components in the aortic media. Structural analysis shows loss of the intimate spatial association between elastin deposits and vascular smooth muscle cells and a marked excess of aortic wall collagen. These characteristics are observed in young children and in the absence of inflammation, suggesting a severe defect in elastogenesis rather than secondary elastic fiber destruction.</p><p>Aortic samples from individuals with LDS had significantly more diffuse medial degeneration than did samples from individuals with Marfan syndrome or control individuals. The changes are not entirely specific for LDS, but in the appropriate clinico-pathologic setting help differentiate it from other vascular diseases [<a class="bk_pop" href="#loeys-dietz.REF.maleszewski.2009.194">Maleszewski et al 2009</a>].</p></div><div id="loeys-dietz.Skeletal"><h4>Skeletal</h4><p>The skeletal findings are characterized by Marfan syndrome-like skeletal features and joint laxity or contractures [<a class="bk_pop" href="#loeys-dietz.REF.erkula.2010.1876">Erkula et al 2010</a>]:</p><p><b>Skeletal overgrowth</b> in LDS is less pronounced than in Marfan syndrome and usually affects the digits more prominently than the long bones.</p><p><b>Arachnodactyly</b> is present in some, but true dolichostenomelia (leading to an increase in the arm span-to-height ratio and a decrease in the upper-to-lower segment ratio) is less common in LDS than in Marfan syndrome.</p><p><b>Combined thumb and wrist signs</b> were present in one third of individuals with LDS.</p><p>Note: (1) The Walker-Murdoch wrist sign is the overlapping of the complete distal phalanx of the thumb and fifth finger when wrapped around the opposite wrist. (2) The "thumb sign" (Steinberg) is an extension of the entire distal phalanx of the thumb beyond the ulnar border of the hand when apposed across the palm.</p><p><b>Overgrowth of the ribs</b> can push the sternum in (pectus excavatum) or out (pectus carinatum).</p><p><b>Joint hypermobility</b> is common and can include <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> hip dislocation and recurrent joint subluxations. Paradoxically, some individuals can show reduced joint mobility, especially of the hands (camptodactyly) and feet (clubfeet).</p><p><b>Spine anomalies,</b> including <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> malformations of the cervical vertebrae and cervical spine instability, are common, especially in individuals with more severe craniofacial features.</p><p>Preliminary data suggest that approximately one third (or more) of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have structural cervical spine anomalies and at least 50% have cervical spine instability.</p><p><b>Other skeletal findings</b></p><ul><li class="half_rhythm"><div>Spondylolisthesis and scoliosis can be mild or severe and progressive.</div></li><li class="half_rhythm"><div>Acetabular protrusion, present in one third of individuals, is usually mild but can be associated with pain or functional limitations.</div></li><li class="half_rhythm"><div><i>Pes planus</i>, often associated with inward rotation at the ankle, contributes to difficulty with ambulation, leg fatigue, and muscle cramps.</div></li><li class="half_rhythm"><div>Preliminary evidence suggests that individuals with LDS have an increased incidence of osteoporosis with increased fracture incidence and delayed bone healing [<a class="bk_pop" href="#loeys-dietz.REF.kirmani.2010.1016">Kirmani et al 2010</a>].</div></li></ul><p>Note: Musculoskeletal findings, including hypotonia, have been observed in neonates with LDS [<a class="bk_pop" href="#loeys-dietz.REF.yetman.2007.e1199">Yetman et al 2007</a>].</p></div><div id="loeys-dietz.Craniofacial"><h4>Craniofacial</h4><p>In their most severe presentation, craniofacial anomalies in individuals with LDS are characterized by widely spaced eyes and craniosynostosis. Craniosynostosis most commonly involves premature fusion of the sagittal suture (resulting in dolichocephaly). Coronal suture synostosis (resulting in brachycephaly) and metopic suture synostosis (resulting in trigonocephaly) have also been described.</p><ul><li class="half_rhythm"><div>Bifid uvula is considered the mildest expression of a cleft palate. Sometimes the uvula has an unusual broad appearance with or without a midline raphe.</div></li><li class="half_rhythm"><div>Other craniofacial characteristics include malar flattening and retrognathia.</div></li></ul></div><div id="loeys-dietz.Cutaneous"><h4>Cutaneous</h4><p>The skin findings, similar to those seen in vascular Ehlers-Danlos syndrome (see <a href="#loeys-dietz.Differential_Diagnosis">Differential Diagnosis</a>), include velvety, thin, translucent skin with visible veins on the chest wall, easy bruising (other than on the lower legs), and slower scar formation and dystrophic scarring.</p></div><div id="loeys-dietz.Allergy_and_Gastrointestinal"><h4>Allergy and Gastrointestinal Disease</h4><p>Individuals with LDS are predisposed to developing allergic disease including asthma, food allergy, eczema, allergic rhinitis, and eosinophilic gastrointestinal disease. Some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have exhibited elevated immunoglobulin E levels, eosinophil counts, and T helper 2 (TH2) cytokines in plasma [<a class="bk_pop" href="#loeys-dietz.REF.frischmeyerguerrerio.2013.195ra94">Frischmeyer-Guerrerio et al 2013</a>, <a class="bk_pop" href="#loeys-dietz.REF.felgentreff.2014.43">Felgentreff et al 2014</a>].</p></div><div id="loeys-dietz.Ocular"><h4>Ocular</h4><p>Myopia is less frequent and less severe than that seen in Marfan syndrome. Significant refractive errors can lead to amblyopia. Other common ocular features include strabismus and blue sclerae. Retinal detachment has been reported in rare cases. Ectopia lentis is not observed.</p></div><div id="loeys-dietz.Other"><h4>Other</h4><p>Life-threatening manifestations include spontaneous rupture of the spleen and bowel, and uterine rupture during pregnancy.</p><p>The two most common neuroradiologic findings are dural ectasia (the precise incidence of which is unknown, as only a minority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have undergone appropriate examination) and Arnold-Chiari type I malformation, which may be relatively rare.</p><p>A minority of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have developmental delay. When present, developmental delay is most often associated with craniosynostosis and/or hydrocephalus, suggesting that learning disability is an extremely rare primary manifestation of LDS.</p><p>Less common associated findings requiring further exploration include submandibular branchial cysts and defective tooth enamel.</p><p><b>Pregnancy.</b> Pregnancy can be dangerous for women with LDS; see <a href="#loeys-dietz.Pregnancy_Management">Pregnancy Management</a>.</p></div></div><div id="loeys-dietz.Phenotype_Correlations_by_Ge"><h3>Phenotype Correlations by Gene</h3><p>Various clinical presentations have in the past been labeled as LDS type I (craniofacial features present), LDS type II (minimal to absent craniofacial features), LDS type III (presence of osteoarthritis), and so on. These subtype designations provide a general indication of the spectrum of disease severity, from most to least severe: LDS1=LDS2&#x0003e;LDS3&#x0003e;LDS4&#x0003e;LDS5. Note: There is not yet enough information on the spectrum of features of LDS caused by <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>SMAD2</i> to place this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> on the continuum or in <a class="figpopup" href="/books/NBK1133/table/loeys-dietz.T.loeysdietz_syndrome_lds_as/?report=objectonly" target="object" rid-figpopup="figloeysdietzTloeysdietzsyndromeldsas" rid-ob="figobloeysdietzTloeysdietzsyndromeldsas">Table 2</a>.</p><div id="loeys-dietz.T.loeysdietz_syndrome_lds_as" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Loeys-Dietz Syndrome (LDS): Associated Genes and Subtypes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.T.loeysdietz_syndrome_lds_as/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.T.loeysdietz_syndrome_lds_as_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Subtype of LDS&#x000a0;<sup>1</sup></th><th id="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th><th id="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference</th></tr></thead><tbody><tr><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFBR1</i></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LDS1&#x000a0;<sup>2</sup></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#loeys-dietz.REF.loeys.2005.275">Loeys et al [2005]</a>, <a class="bk_pop" href="#loeys-dietz.REF.loeys.2006.788">Loeys et al [2006]</a></td></tr><tr><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFBR2</i></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LDS2&#x000a0;<sup>2</sup></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMAD3</i></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LDS3&#x000a0;<sup>3</sup></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Strong predisposition for osteoarthritis&#x000a0;<sup>4</sup></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#loeys-dietz.REF.van_de_laar.2011.121">van de Laar et al [2011]</a></td></tr><tr><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFB2</i></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">LDS4</td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Systemic findings possibly less severe &#x00026; more like Marfan syndrome&#x000a0;<sup>5</sup></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#loeys-dietz.REF.lindsay.2012.922">Lindsay et al [2012]</a>, <a class="bk_pop" href="#loeys-dietz.REF.bertoliavella.2015.1324">Bertoli-Avella et al [2015]</a></td></tr><tr><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFB3</i></td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LDS5</td><td headers="hd_h_loeys-dietz.T.loeysdietz_syndrome_lds_as_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="loeys-dietz.TF.2.1"><p class="no_margin">Ordered from most to least severe</p></div></dd><dt>2. </dt><dd><div id="loeys-dietz.TF.2.2"><p class="no_margin">No differences in <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> are observed between individuals with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TGFBR1</i> and those with a heterozygous pathogenic variant in <i>TGFBR2</i>.</p></div></dd><dt>3. </dt><dd><div id="loeys-dietz.TF.2.3"><p class="no_margin">The severity of aortic disease in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SMAD3</i> is similar to that associated with a heterozygous pathogenic variant in <i>TGFBR1</i> or <i>TGFBR2</i>.</p></div></dd><dt>4. </dt><dd><div id="loeys-dietz.TF.2.4"><p class="no_margin">Several individuals with a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>SMAD3</i> who do not have osteoarthritis have been reported [<a class="bk_pop" href="#loeys-dietz.REF.wischmeijer.2013.1028">Wischmeijer et al 2013</a>].</p></div></dd><dt>5. </dt><dd><div id="loeys-dietz.TF.2.5"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.boileau.2012.916">Boileau et al [2012]</a></p></div></dd></dl></div></div></div></div><div id="loeys-dietz.GenotypePhenotype_Correlatio"><h3>Genotype-Phenotype Correlations</h3><p>While the implicated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> can correlate broadly with disease severity (see <a href="#loeys-dietz.Phenotype_Correlations_by_Ge">Phenotype Correlations by Gene</a>), there are few specific <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> in LDS. Wide intrafamilial phenotypic variability has been documented. The identical <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has also been described in unrelated <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with phenotypes ranging from predominantly thoracic aortic disease to classic and severe LDS. These data suggest the strong influence of genetic modifiers of disease that are independent of the pathogenic variant itself.</p></div><div id="loeys-dietz.Penetrance"><h3>Penetrance</h3><p>Intrafamilial clinical variability has been described and rare examples of non-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in LDS have been documented. In one case, this was related to <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>; in another, no evidence for mosaicism was observed.</p><p>Intrafamilial variability likely relates to genetic modification; genes encoding factors that regulate TGF&#x003b2; signaling are excellent candidates for sites of modifying variation.</p></div><div id="loeys-dietz.Nomenclature"><h3>Nomenclature</h3><p>Marfan syndrome type 2 was a designation initially applied by <a class="bk_pop" href="#loeys-dietz.REF.mizuguchi.2004.855">Mizuguchi et al [2004]</a> to describe individuals with "classic" Marfan syndrome caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TGFBR2</i>. At the time of the report other discriminating features of LDS had not yet been described. There has not been documentation of individuals with a heterozygous pathogenic variant in<i>TGFBR1</i> or <i>TGFBR2</i> that satisfied diagnostic criteria for Marfan syndrome including the stipulation requiring absence of discriminating features of LDS [<a class="bk_pop" href="#loeys-dietz.REF.loeys.2006.788">Loeys et al 2006</a>, <a class="bk_pop" href="#loeys-dietz.REF.van_hemelrijk.2010.546">Van Hemelrijk et al 2010</a>]. The term Marfan syndrome type 2 should not be used to refer to LDS.</p></div><div id="loeys-dietz.Prevalence"><h3>Prevalence</h3><p>The prevalence of LDS is unknown.</p><p>Neither apparent enrichment in any ethnic or racial group nor gender preference has been reported.</p></div><div id="loeys-dietz.Genetically_Related_Allelic"><h3>Genetically Related (Allelic) Disorders</h3><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with pathogenic variants in <i>SMAD3</i>, <i>TGFB2</i>, or <i>TGFB3.</i> While pathogenic variants in <i>TGFB3</i> have been associated with Rienhof syndrome, this <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is clinically related to Loeys-Dietz syndrome<i>.</i></p><p><b><i>SMAD2</i>.</b> Two pathogenic variants in <i>SMAD2</i> have been reported in a series of 362 individuals with severe <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart disease [<a class="bk_pop" href="#loeys-dietz.REF.zaidi.2013.220">Zaidi et al 2013</a>]. These two individuals presented with dextrocardia associated with multiple other congenital heart defects.</p><p><b><i>TGFBR1</i> and <i>TGFBR2</i>.</b> A number of disorders have been thought to be caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TGFBR1</i> or <i>TGFBR2</i> (see <a href="#loeys-dietz.Differential_Diagnosis">Differential Diagnosis</a>).</p><p>The only disorder not clinically related to Loeys-Dietz syndrome that is caused by a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variant in <i>TGFBR1</i> is multiple self-healing squamous epithelioma, also known as Ferguson-Smith disease [<a class="bk_pop" href="#loeys-dietz.REF.goudie.2011.365">Goudie et al 2011</a>].</p></div></div><div id="loeys-dietz.Differential_Diagnosis"><h2 id="_loeys-dietz_Differential_Diagnosis_">Differential Diagnosis</h2><div id="loeys-dietz.Syndromic_Forms_of_Thoracic"><h3>Syndromic Forms of Thoracic Aortic Aneurysms</h3><p><a href="/books/n/gene/marfan/"><b>Marfan syndrome</b></a> is a systemic disorder with a high degree of clinical variability. Cardinal manifestations involve the ocular, skeletal, and cardiovascular systems [<a class="bk_pop" href="#loeys-dietz.REF.judge.2005.1965">Judge &#x00026; Dietz 2005</a>]. Cardiovascular manifestations include dilatation of the aorta at the level of the sinuses of Valsalva, a predisposition for aortic tear and rupture, mitral valve prolapse with or without regurgitation, tricuspid valve prolapse, and enlargement of the proximal pulmonary artery. Marfan syndrome is caused by mutation of <i>FBN1</i> and inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p><a href="/books/n/gene/sgs/"><b>Shprintzen-Goldberg syndrome</b></a>
<b>(SGS)</b> is characterized by craniosynostosis, distinctive craniofacial features, skeletal changes, neurologic abnormalities, mild-to-moderate intellectual disability, and brain anomalies. Cardiovascular anomalies (mitral valve prolapse, mitral regurgitation, and aortic regurgitation) may occur, but aortic root dilatation is less commonly observed than in LDS, and can be mild. An important feature distinguishing SGS from LDS is the near-uniform incidence of developmental delay in SGS.</p><p>Molecular analysis of a series of individuals with typical SGS did not reveal pathogenic variants in <i>TGFBR1</i> or <i>TGFBR2</i> [<a class="bk_pop" href="#loeys-dietz.REF.loeys.2005.275">Loeys et al 2005</a>]. Affected individuals are usually <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> cases (i.e., no family history of SGS), although rare instances of apparent <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> inheritance have been described. Most individuals with SGS have a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant in <i>SKI</i> [<a class="bk_pop" href="#loeys-dietz.REF.carmignac.2012.950">Carmignac et al 2012</a>, <a class="bk_pop" href="#loeys-dietz.REF.doyle.2012.1249">Doyle et al 2012</a>]. The SKI protein is a known repressor of TGF&#x003b2; signaling, functionally linking SGS to LDS. Note: An individual reported with SGS by <a class="bk_pop" href="#loeys-dietz.REF.kosaki.2006.104">Kosaki et al [2006]</a> was felt to have LDS based on the presence of arterial tortuosity and a bifid uvula [<a class="bk_pop" href="#loeys-dietz.REF.robinson.2006.109">Robinson et al 2006</a>].</p><div id="loeys-dietz.T.clinical_features_of_loeys" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Clinical Features of Loeys-Dietz Syndrome by Associated Gene Compared to the Clinical Features of Marfan Syndrome and Shprintzen-Goldberg Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.T.clinical_features_of_loeys/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.T.clinical_features_of_loeys_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" style="text-align:left;vertical-align:middle;">Clinical Feature</th><th id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Marfan<br />Syndrome</th><th id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3" colspan="5" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Loeys-Dietz Syndrome</th><th id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Shprintzen<br />-Goldberg<br />Syndrome</th></tr><tr><th headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2" id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;"><i>FBN1</i></th><th headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3" id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFBR1</i>/<br /><i>TGFBR2</i></th><th headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3" id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SMAD3</i></th><th headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3" id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFB2</i></th><th headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3" id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>TGFB3</i></th><th headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3" id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">SMAD2</th><th headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4" id="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SKI</i></th></tr></thead><tbody><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Developmental delay</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Ectopia lentis</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cleft palate / bifid uvula</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Widely spaced eyes</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Craniosynostosis</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Tall stature</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Arachnodactyly</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pectus deformity</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clubfoot</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Osteoarthritis</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Aortic root aneurysm</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Arterial aneurysm</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Arterial tortuosity</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Early dissection</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bicuspid aortic valve</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mitral valve insufficiency</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Striae</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dural ectasia</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_2 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_3 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_1_4 hd_h_loeys-dietz.T.clinical_features_of_loeys_1_1_2_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>+ </dt><dd><div id="loeys-dietz.TF.3.1"><p class="no_margin">= feature is present; the presence of more than one "+" indicates that a feature is more common, with "+++" indicating most common.</p></div></dd><dt></dt><dd><div><p class="no_margin">&#x02212; = feature is absent.</p></div></dd></dl></div></div></div><p><b><i>BGN</i>-associated aortic aneurysm syndrome</b> is an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> condition caused by a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>BGN</i>, coding for biglycan [<a class="bk_pop" href="#loeys-dietz.REF.meester.2017.582">Meester et al 2017</a>]. Clinical features significantly overlap with both Marfan syndrome and Loeys-Dietz syndrome, including early-onset aortic root dilatation and dissection, widely spaced eyes, joint hypermobility, contractures, bifid uvula, and pectus deformities. In some families, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females are also <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. The type of pathogenic variants in <i>BGN</i> suggest loss of function as the mechanism of disease.</p><p><b>MASS <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a></b> (OMIM <a href="http://omim.org/entry/604308" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">604308</a>) is characterized by <i>m</i>itral valve prolapse, <i>m</i>yopia, borderline and non-progressive <i>a</i>ortic enlargement, and nonspecific <i>s</i>kin and <i>s</i>keletal findings that overlap with those seen in Marfan syndrome. One is most confident in this diagnosis when concordant manifestations are seen in multiple generations in a given family. However, some individuals in such a family could be predisposed to more severe vascular involvement, and thus a regimen of intermittent cardiovascular imaging should be maintained. It is difficult to distinguish MASS phenotype from "emerging" Marfan syndrome when assessing a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., single occurrence in a family), especially during childhood. Heterozygous variants in <i>FBN1</i> can be causative. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>The Ehlers-Danlos syndromes</b></p><div id="loeys-dietz.T.selected_ehlersdanlos_synd" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Selected Ehlers-Danlos Syndrome (EDS) Subtypes</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.T.selected_ehlersdanlos_synd/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.T.selected_ehlersdanlos_synd_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disease Name</th><th id="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene(s)</th><th id="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical Features/Comments</th></tr></thead><tbody><tr><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds/">Classic EDS</a> (cEDS)</td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL5A1</i><br /><i>COL5A2</i><br /><i>COL1A1</i>&#x000a0;<sup>1</sup></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_4" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">In cEDS &#x00026; hEDS:
<ul><li class="half_rhythm"><div>Some individuals have aortic root enlargement, but progression of the dilatation &#x00026; predisposition for aortic dissection have not been established.&#x000a0;<sup>2</sup></div></li><li class="half_rhythm"><div>No history of sudden death also argues against progressive aortic root dilatation.</div></li></ul>
</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds3/">Hypermobile EDS (hEDS)</a></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown/<br /><i>TNXB&#x000a0;<sup>3</sup></i></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds4/">Vascular EDS</a> (vEDS)</td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL3A1</i><br /><i>COL1A1</i>&#x000a0;<sup>4</sup></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD&#x000a0;<sup>5</sup></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">If:
<ul><li class="half_rhythm"><div>vEDS clinically suspected</div></li><li class="half_rhythm"><div>Normal collagen biochemistry</div></li><li class="half_rhythm"><div>Absence of a <i>COL3A1</i> or <i>COL1A1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></div></li></ul>
Consider LDS/molecular analysis of <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>, <i>TGFBR1</i>, &#x00026; <i>TGFBR2</i>.&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac-valvular EDS (cvEDS)<br />OMIM <a href="http://omim.org/entry/225320" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">225320</a></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>COL1A2</i></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Features of cvEDS&#x000a0;<sup>6</sup>:
<ul><li class="half_rhythm"><div>Joint hypermobility</div></li><li class="half_rhythm"><div>Skin hyperextensibility</div></li><li class="half_rhythm"><div>Severe cardiac valvular defects</div></li></ul>
</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/eds6/">Kyphoscoliotic EDS</a> (kEDS)</td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PLOD1</i></td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_loeys-dietz.T.selected_ehlersdanlos_synd_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In kEDS:
<ul><li class="half_rhythm"><div>Risk for rupture of medium-sized arteries &#x00026; respiratory compromise if kyphoscoliosis is severe</div></li><li class="half_rhythm"><div>Aortic dilation &#x00026; rupture variably seen</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a href="/books/n/gene/glossary/def-item/mode-of-inheritance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AD = <a href="/books/n/gene/glossary/def-item/autosomal-dominant/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">autosomal dominant</a></p></div></dd><dt></dt><dd><div><p class="no_margin">AR = <a href="/books/n/gene/glossary/def-item/autosomal-recessive/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">autosomal recessive</a></p></div></dd><dt>1. </dt><dd><div id="loeys-dietz.TF.4.1"><p class="no_margin">Mutation of <i>COL1A1</i> is not a major cause of cEDS [<a class="bk_pop" href="#loeys-dietz.REF.malfait.2005.28">Malfait et al 2005</a>]. See <a href="/books/n/gene/eds/">EDS, Classic Type</a>.</p></div></dd><dt>2. </dt><dd><div id="loeys-dietz.TF.4.2"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.wenstrup.2002.112">Wenstrup et al [2002]</a></p></div></dd><dt>3. </dt><dd><div id="loeys-dietz.TF.4.3"><p class="no_margin">In most individuals with hEDS, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in which mutation is causative is unknown and unmapped. Haploinsufficiency of tenascin-X (encoded by <i>TNXB</i>) has been associated with hEDS in a small subset of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div></dd><dt>4. </dt><dd><div id="loeys-dietz.TF.4.4"><p class="no_margin">Arginine-to-cysteine pathogenic variants in <i>COL1A1</i> have been identified in a subset of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who typically present with aneurysms of the abdominal aorta and iliac arteries reminiscent of vEDS. Distinct abnormalities on collagen electrophoresis are observed [<a class="bk_pop" href="#loeys-dietz.REF.malfait.2007.387">Malfait et al 2007</a>].</p></div></dd><dt>5. </dt><dd><div id="loeys-dietz.TF.4.5"><p class="no_margin">vEDS is almost always inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, but rare examples of <a class="def" href="/books/n/gene/glossary/def-item/biallelic/">biallelic</a> inheritance have been reported.</p></div></dd><dt>6. </dt><dd><div id="loeys-dietz.TF.4.6"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.schwarze.2004.917">Schwarze et al [2004]</a></p></div></dd></dl></div></div></div><p><a href="/books/n/gene/cca/"><b>Congenital contractural arachnodactyly</b></a>
<b>(CCA)</b> is characterized by a Marfan-like appearance (tall, slender habitus in which arm span exceeds height) and long, slender fingers and toes (arachnodactyly). Progressive enlargement of the ascending aorta at the sinuses of Valsalva has been reported, but there is no evidence that the aortic dilatation progresses to dissection or rupture [<a class="bk_pop" href="#loeys-dietz.REF.gupta.2002.39">Gupta et al 2002</a>]. Infants have been observed with a severe/lethal form characterized by multiple cardiovascular and gastrointestinal anomalies in addition to the typical skeletal findings. CCA is caused by mutation of <i>FBN2</i> and is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p><p><a href="/books/n/gene/arterial-t/"><b>Arterial tortuosity syndrome</b></a>
<b>(ATS)</b> is a rare <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> connective tissue disorder, mainly characterized by severe tortuosity, stenosis, and aneurysms of the aorta and middle-sized arteries [<a class="bk_pop" href="#loeys-dietz.REF.wessels.2004.134">Wessels et al 2004</a>]. Skeletal and skin involvement is also common. The underlying genetic defect is homozygosity for <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants in <i>SLC2A10</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding solute carrier family 2, facilitated glucose transporter member 10. Although a glucose transporter defect would not be expected to cause abnormal arterial patterning, additional studies indicated upregulation of the TGF&#x003b2; signaling pathway [<a class="bk_pop" href="#loeys-dietz.REF.coucke.2006.452">Coucke et al 2006</a>], consistent with the pathophysiology in LDS and Marfan syndrome.</p></div><div id="loeys-dietz.Other_Syndromes_Associated_w"><h3>Other Syndromes Associated with Ascending Aortic Aneurysms</h3><p><b>Turner syndrome,</b> one of the most common sex <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/aneuploidy/">aneuploidy</a> syndromes, is caused by the loss of one of the X chromosomes (45,X). The most important phenotypic features are short stature, gonadal dysgenesis, neck webbing, and an increased incidence of renal and cardiovascular abnormalities. The latter include bicuspid aortic valve (BAV), coarctation of the aorta, and thoracic aortic aneurysms. Aortic root dilation is observed in up to 40% of women with Turner syndrome, but the frequency with which it leads to aortic dissection is unknown. Current health surveillance recommendations for Turner syndrome include echocardiography or MRI for evaluation of the diameter of the aortic root and ascending aorta at least every five years.</p><p><a href="/books/n/gene/noonan/"><b>Noonan syndrome</b></a> is characterized by short stature, <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> heart defect, and developmental delay of variable degree. Congenital heart disease occurs in 50%-80% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Pulmonary valve stenosis, often with dysplasia, is the most common heart defect and is found in 20%-50% of affected individuals. Hypertrophic cardiomyopathy, found in 20%-30% of affected individuals, may be present at birth or appear in infancy or childhood. Other structural defects frequently observed include atrial and ventricular septal defects, branch pulmonary artery stenosis, and tetralogy of Fallot. Rarely, aortic aneurysms have been described. Noonan syndrome is caused by mutation of <i>BRAF</i>, <i>KRAS</i>, <i>MAP2K1</i>, <i>NRAS</i>, <i>PTPN11</i>, <i>SOS1</i>, <i>RAF1</i>, or <i>RIT1</i>. Inheritance is <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>.</p><p><b>Cutis laxa.</b> Autosomal dominant cutis laxa (ADCL) was historically considered a strictly cutaneous disorder without systemic involvement, in contrast to <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> cutis laxa (ARCL), which is associated with high morbidity and mortality resulting from pulmonary emphysema and aortic aneurysms.</p><div id="loeys-dietz.T.cutis_laxa_subtypes_to_con" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p>Cutis Laxa Subtypes to Consider in the Differential Diagnosis of Loeys-Dietz Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.T.cutis_laxa_subtypes_to_con/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.T.cutis_laxa_subtypes_to_con_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_1" style="text-align:left;vertical-align:middle;">Disease Name</th><th id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_2" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_3" style="text-align:left;vertical-align:middle;">OMIM</th><th id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_4" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5" colspan="5" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Findings</th></tr><tr><th headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5" id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Cutis laxa</th><th headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5" id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Emphysema</th><th headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5" id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Aneurysms</th><th headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5" id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID</th><th headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5" id="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">GI &#x00026; GU malformations</th></tr></thead><tbody><tr><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/fbln5-cutis-laxa/"><i>FBLN5</i>-related cutis laxa</a></td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FBLN5</i></td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://www.omim.org/entry/219100" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">219100</a></td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td></tr><tr><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/efemp2-cutis-laxa/"><i>EFEMP2</i>-related cutis laxa</a></td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>EFEMP2</i> (<i>FBLN4</i>)</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://www.omim.org/entry/614437" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614437</a></td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">++</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+++</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td></tr><tr><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ADCL</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ELN</i> or <i>FBLN5</i></td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="http://www.omim.org/entry/123700" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">123700</a><br /><a href="http://www.omim.org/entry/614434" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">614434</a></td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">+</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td><td headers="hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_1_5 hd_h_loeys-dietz.T.cutis_laxa_subtypes_to_con_1_1_2_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02212;</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a></p></div></dd><dt></dt><dd><div><p class="no_margin">ID = intellectual disability</p></div></dd></dl></div></div></div></div><div id="loeys-dietz.Nonsyndromic_Familial_Thorac"><h3>Nonsyndromic Familial Thoracic Aortic Aneurysms and Dissections</h3><p><b>Bicuspid aortic valve with thoracic aortic aneurysm (BAV/TAA).</b> Many cases of a dilated ascending aorta are associated with an underlying BAV. A bicuspid aortic valve is present in 1%-2% of the general population. Among persons with aortic dissection detected at postmortem examination, 8% have BAVs. Histologic studies show elastin degradation and cystic medial necrosis in the aorta above the valve. For a long time, it was believed that the aneurysms were caused by "post-stenotic dilatation" of the ascending aorta. However, echocardiography of young persons with normally functioning BAVs shows that aortic root dilatation is common (52%) [<a class="bk_pop" href="#loeys-dietz.REF.nistri.1999.19">Nistri et al 1999</a>]. Importantly, the aortic dilation often occurs above the sinuses of Valsalva.</p><p>BAVs cluster in families and are found in 9% of first-degree relatives of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Family members of probands with BAV and aneurysm can show aneurysm and dissection in the absence of the accompanying valve abnormality, suggesting that both BAV and aneurysm represent primary manifestations of the underlying <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> defect [<a class="bk_pop" href="#loeys-dietz.REF.loscalzo.2007.1960">Loscalzo et al 2007</a>]. In family studies, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is common.</p><p>Thus far, pathogenic variants have been identified in <i>NOTCH1</i> (OMIM <a href="http://omim.org/entry/190198" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">190198</a>) and <i>SMAD6</i> (OMIM <a href="http://omim.org/entry/602931" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">602931</a>) in rare individuals with additional <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> cardiac malformations. <i>NOTCH1</i> pathogenic variants appear specific to individuals and families with significant valve calcification and stenosis, findings not observed in most families with BAV/TAA. Linkage analysis suggests genetic heterogeneity with loci identified on chromosomes 18q, 5q, and 13q [<a class="bk_pop" href="#loeys-dietz.REF.martin.2007.275">Martin et al 2007</a>]. <i>SMAD6</i> <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants account for about 2% of all cases of BAV/TAA [<a class="bk_pop" href="#loeys-dietz.REF.gillis.2017.400">Gillis et al 2017</a>].</p><p><b>Persistent patent ductus arteriosus with thoracic aortic aneurysm (PDA/TAA).</b> A report describing a single large family with 179 members who have a high incidence of thoracic aortic aneurysm and dissection (TAAD) in conjunction with PDA suggests that a novel genetic defect underlies both vascular conditions in this family. Linkage analysis excluded all known genes or loci implicated in <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> TAAD or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> PDA. The disease was mapped to <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 16p12 [<a class="bk_pop" href="#loeys-dietz.REF.khau_van_kien.2005.200">Khau Van Kien et al 2005</a>]. Mutation of <i>MYH11</i> (encoding myosin-11, a specific contractile protein of smooth muscle cells) is causative. The structural defect leads to lower aortic compliance, smooth muscle cell loss, and elastolysis, but the precise pathophysiology remains unclear [<a class="bk_pop" href="#loeys-dietz.REF.zhu.2006.343">Zhu et al 2006</a>].</p><p><b>Fibromuscular dysplasia (FMD)</b> (OMIM <a href="http://omim.org/entry/135580" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">135580</a>) is a nonatherosclerotic, noninflammatory vascular disease that can affect almost every artery, but most frequently affects the renal and internal carotid arteries. Most commonly, medial hyperplasia leads to a classic "strings of beads" stenotic arterial appearance. Macro-aneurysms and dissections are complications. It is possible that genetic factors play a role in the pathogenesis: the disease is observed among the first-degree relatives of persons with fibromuscular dysplasia of the renal arteries. The underlying genetic cause for nonsyndromic FMD has not been identified, although <i>PHACTR1</i> has been reported as a genetic susceptibility <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> for FMD [<a class="bk_pop" href="#loeys-dietz.REF.kiando.2016.e100636">Kiando et al 2016</a>].</p><p><a href="/books/n/gene/taa/"><b>Familial thoracic aortic aneurysm and dissection</b></a>
<b>(FTAAD).</b> Cardiovascular manifestations of FTAAD include the following:</p><ul><li class="half_rhythm"><div>Dilatation of the aorta at the level of either the ascending aorta or the sinuses of Valsalva</div></li><li class="half_rhythm"><div>Aneurysms and dissections of the thoracic aorta involving either the ascending or descending aorta</div></li></ul><p>TAAD is diagnosed based on the presence of dilatation and/or dissection of the thoracic aorta, absence of Marfan syndrome and other connective tissue abnormalities, and presence of a positive family history.</p><p>Cardiovascular manifestations are usually the only findings. Affected individuals typically have progressive enlargement of the ascending aorta leading to either aortic dissection involving the ascending aorta (type A dissection) or consequent tear or rupture. The onset and rate of progression of aortic dilatation is highly variable; however, persons with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> TAAD present with aortic disease at a mean age of 56.8 years, which is younger than that for <a class="def" href="/books/n/gene/glossary/def-item/sporadic/">sporadic</a> TAAD (64.3 years) but significantly older than that for Marfan syndrome (24.8 years) [<a class="bk_pop" href="#loeys-dietz.REF.coady.1999.361">Coady et al 1999</a>].</p><div id="loeys-dietz.T.selected_causes_of_heritab" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Selected Causes of Heritable Thoracic Aortic Disease (HTAD)</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.T.selected_causes_of_heritab/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.T.selected_causes_of_heritab_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene/(Locus)&#x000a0;<sup>1,&#x000a0;2</sup></th><th id="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of HTAD Attributed to Mutation of This Gene</th><th id="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Findings</th></tr></thead><tbody><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ACTA2</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12%-21%&#x000a0;<sup>3</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">In some: livido reticularis, iris flocculi, cerebral aneurysm, bicuspid aortic valve, &#x00026; persistent patent ductus arteriosus</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYH11</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>4</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Other cardiovascular finding: patent ductus arteriosus&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MYLK</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>6</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Aortic dissections w/minimal enlargement but limited experience; no associated features</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>PRKG1</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>7</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Type A &#x00026; B aortic dissections associated w/tortuosity &#x00026; hypertension</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAT2A</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>8</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Other cardiovascular finding: bicuspid aortic valve</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FOXE3</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>9</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males described; no associated features</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MFAP5</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c; 1%&#x000a0;<sup>10</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Mild systemic features; associated w/lone paroxysmal atrial fibrillation</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>LOX</i></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1%&#x000a0;<sup>11</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Associated w/bicuspid aortic valve, mild marfanoid features</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(AAT1 or FAA1)&#x000a0;<sup>12</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">More diffuse vascular disease than in TAAD1, w/aneurysms affecting both thoracic &#x00026; abdominal aorta &#x00026; other arteries</td></tr><tr><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">(AAT2 or TAAD1)&#x000a0;<sup>12</sup></td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td><td headers="hd_h_loeys-dietz.T.selected_causes_of_heritab_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Heritable thoracic aortic disease (HTAD) refers to thoracic aortic disease caused by mutation of a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> that confers a high risk for thoracic aortic aneurysms and aortic dissections (see <a href="/books/n/gene/taa/">Heritable Thoracic Aortic Disease Overview</a>).</p></div></dd><dt>1. </dt><dd><div id="loeys-dietz.TF.6.1"><p class="no_margin">Locus is included when associated <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is not known.</p></div></dd><dt>2. </dt><dd><div id="loeys-dietz.TF.6.2"><p class="no_margin"><i>TGFBR2</i> pathogenic variants all affecting the same codon (p.Arg460His and p.Arg460Cys) were found in four of 80 unrelated families with <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> TAAD. Although the majority of vascular disease in these families involved ascending aortic aneurysms leading to type A dissections, <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members also had characteristic findings of LDS including descending aortic disease and aneurysms of other arteries (e.g., cerebral, carotid, and popliteal arteries) and other connective tissue findings (e.g., pectus deformity and joint hypermobility). Furthermore, the identical <i>TGFBR2</i> pathogenic variants reported in FTAAD have been observed in multiple families with typical features of LDS [<a class="bk_pop" href="#loeys-dietz.REF.loeys.2006.788">Loeys et al 2006</a>; Authors, unpublished data]. Currently, it is unclear whether a <i>TGFBR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can lead to an <a class="def" href="/books/n/gene/glossary/def-item/isolated/">isolated</a> aortic aneurysm <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (i.e., FTAAD); thus, use of the term FTAAD to refer to families with TAAD and a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a><i>TGFBR2</i> pathogenic variant does not seem appropriate.</p></div></dd><dt>3. </dt><dd><div id="loeys-dietz.TF.6.3"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.guo.2007.1488">Guo et al [2007]</a>, <a class="bk_pop" href="#loeys-dietz.REF.morisaki.2009.1406">Morisaki et al [2009]</a>, <a class="bk_pop" href="#loeys-dietz.REF.disabella.2011.321">Disabella et al [2011]</a>, <a class="bk_pop" href="#loeys-dietz.REF.hoffjan.2011.520">Hoffjan et al [2011]</a>, <a class="bk_pop" href="#loeys-dietz.REF.renard.2013.314">Renard et al [2013]</a></p></div></dd><dt>4. </dt><dd><div id="loeys-dietz.TF.6.4"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.pannu.2007.2453">Pannu et al [2007]</a></p></div></dd><dt>5. </dt><dd><div id="loeys-dietz.TF.6.5"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.glancy.2001">Glancy et al [2001]</a>, <a class="bk_pop" href="#loeys-dietz.REF.khau_van_kien.2004.173">Khau Van Kien et al [2004]</a>, <a class="bk_pop" href="#loeys-dietz.REF.khau_van_kien.2005.200">Khau Van Kien et al [2005]</a>, <a class="bk_pop" href="#loeys-dietz.REF.zhu.2006.343">Zhu et al [2006]</a>, <a class="bk_pop" href="#loeys-dietz.REF.pannu.2007.2453">Pannu et al [2007]</a></p></div></dd><dt>6. </dt><dd><div id="loeys-dietz.TF.6.6"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.wang.2010.701">Wang et al [2010]</a>, <a class="bk_pop" href="#loeys-dietz.REF.luyckx.2017.444">Luyckx et al [2017]</a></p></div></dd><dt>7. </dt><dd><div id="loeys-dietz.TF.6.7"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.guo.2013.398">Guo et al [2013]</a></p></div></dd><dt>8. </dt><dd><div id="loeys-dietz.TF.6.8"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.guo.2015.170">Guo et al [2015]</a>. Two loci designated as AAT1 (FAA1) [<a class="bk_pop" href="#loeys-dietz.REF.vaughan.2001.2469">Vaughan et al 2001</a>] and AAT2 (TAAD1) [<a class="bk_pop" href="#loeys-dietz.REF.guo.2001.2461">Guo et al 2001</a>] are implicated in TAAD; the genes have not been identified.</p></div></dd><dt>9. </dt><dd><div id="loeys-dietz.TF.6.9"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.kuang.2016.948">Kuang et al [2016]</a></p></div></dd><dt>10. </dt><dd><div id="loeys-dietz.TF.6.10"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.barbier.2014.736">Barbier et al [2014]</a></p></div></dd><dt>11. </dt><dd><div id="loeys-dietz.TF.6.11"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.guo.2016.928">Guo et al [2016]</a></p></div></dd><dt>12. </dt><dd><div id="loeys-dietz.TF.6.12"><p class="no_margin"><a class="bk_pop" href="#loeys-dietz.REF.guo.2007.1488">Guo et al [2007]</a></p></div></dd></dl></div></div></div></div></div><div id="loeys-dietz.Management"><h2 id="_loeys-dietz_Management_">Management</h2><div id="loeys-dietz.Evaluations_Following_Initia"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Loeys-Dietz syndrome (LDS), the following evaluations are recommended if they were not completed as part of the evaluation that led to the diagnosis:</p><ul><li class="half_rhythm"><div class="half_rhythm">Echocardiography. Aortic root measurements must be interpreted based on consideration of normal values for age and body size [<a class="bk_pop" href="#loeys-dietz.REF.roman.1989.507">Roman et al 1989</a>]. Select findings (e.g., severe aortic dilatation) may require the immediate attention of a cardiologist or cardiothoracic surgeon.</div></li><li class="half_rhythm"><div class="half_rhythm">MRA or CT scan with 3D reconstruction from head to pelvis to identify arterial aneurysms and arterial tortuosity throughout the arterial tree</div><div class="half_rhythm">Note: Approximately half of the individuals with LDS studied had an aneurysm distant from the aortic root that would not have been detected by echocardiography.</div></li><li class="half_rhythm"><div class="half_rhythm">Radiographs (including flexion and extension views of the cervical spine) to detect skeletal manifestations that may require attention by an orthopedist (e.g., severe scoliosis, cervical spine instability)</div></li><li class="half_rhythm"><div class="half_rhythm">Craniofacial examination for evidence of cleft palate and craniosynostosis</div></li><li class="half_rhythm"><div class="half_rhythm">Eye examination by an ophthalmologist with expertise in connective tissue disorders, including: slit-lamp examination through a maximally dilated pupil for exclusion of lens (sub)luxation; careful refraction and visual correction, especially in young children at risk for amblyopia; specific assessment for retinal detachment</div></li><li class="half_rhythm"><div class="half_rhythm">Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="loeys-dietz.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Management of LDS is most effective through the coordinated input of a multidisciplinary team of specialists including a clinical geneticist, cardiologist, ophthalmologist, orthopedist, and cardiothoracic surgeon. An extensive review of management guidelines has been published [<a class="bk_pop" href="#loeys-dietz.REF.maccarrick.2014">MacCarrick et al 2014</a>] (<a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131122/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><div id="loeys-dietz.Cardiovascular_1"><h4>Cardiovascular</h4><p>All individuals with LDS should be managed in a medical center familiar with this condition.</p><p>Two important considerations when managing cardiovascular features of LDS:</p><ul><li class="half_rhythm"><div>Aortic dissection occurs at smaller aortic diameters than observed in <a href="/books/n/gene/marfan/">Marfan syndrome</a>.</div></li><li class="half_rhythm"><div>Vascular disease is not limited to the aortic root. Imaging of the complete arterial tree from the head through the pelvis by MRA or CTA is necessary.</div></li></ul><p>Beta-adrenergic blockers or angiotensin receptor blockers (ARBs) are used to reduce hemodynamic stress. No clinical trials evaluating the efficacy of beta-adrenergic blockers verses ARBs have been completed in individuals with LDS.</p><p>Aneurysms are amenable to early and aggressive surgical intervention (in contrast to <a href="/books/n/gene/eds4/">vascular EDS</a>, in which surgery is used as a last resort because of the extremely high rate of intraoperative complications and death). Many individuals can undergo a valve-sparing procedure that precludes the need for chronic anticoagulation.</p><p>Given the safety and the increasing availability of the valve-sparing procedure:</p><ul><li class="half_rhythm"><div>For young children with the most severe systemic findings of LDS, surgical repair of the ascending aorta should be considered once the maximal dimension exceeds the 99th percentile and the aortic annulus exceeds 1.8-2.0 cm, allowing the placement of a graft of sufficient size to accommodate growth. Additional factors including family history, rate of aortic root growth, and aortic valve function can influence the timing of surgery.</div></li><li class="half_rhythm"><div>For adolescents and adults, surgical repair of the ascending aorta should be considered once the maximal dimension approaches 4.0 cm. This recommendation is based on both numerous examples of documented aortic dissection in adults with aortic root dimensions at or below 4.0 cm and the excellent response to prophylactic surgery. An extensive family history of larger aortic dimension without dissection could alter this practice for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li><li class="half_rhythm"><div>Note: This practice may not eliminate risk of dissection and death, and earlier intervention based on family history or the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual's personal assessment of risk versus benefit may be indicated.</div></li></ul></div><div id="loeys-dietz.Skeletal_1"><h4>Skeletal</h4><p>Surgical fixation of cervical spine instability may be necessary to prevent damage to the spinal cord.</p><p>Clubfeet require surgical correction by an orthopedic surgeon.</p><p>Bone overgrowth and ligamentous laxity can lead to severe problems (including progressive scoliosis) and should be managed by an orthopedist; surgical stabilization of the spine may be required.</p><p>Pectus excavatum can be severe; rarely, surgical intervention is medically (rather than cosmetically) indicated.</p><p>Surgical intervention for protusio acetabulae is rarely indicated. Treatment focuses on pain control.</p><p>Orthotics are only indicated for severe <i>pes planus</i>. Some individuals prefer use of arch supports; others find them irritating; the choice should be left to personal preference. Surgical intervention is rarely indicated or successful.</p></div><div id="loeys-dietz.Craniofacial_1"><h4>Craniofacial</h4><p>Cleft palate and craniosynostosis require management by a craniofacial team. Treatment of cleft palate and craniosynostosis is the same as in all other disorders with these malformations.</p></div><div id="loeys-dietz.AllergicInflammatory"><h4>Allergic/Inflammatory</h4><p>Standard treatment for allergic complications such as seasonal allergies, food allergies, asthma, and eczema should apply. Referral to an allergist/immunologist may be considered in severe cases. Inflammatory or allergic gastrointestinal findings are treated in the standard fashion with the guidance of a gastroenterologist.</p></div><div id="loeys-dietz.Ocular_1"><h4>Ocular</h4><p>The ocular manifestations of LDS should be managed by an ophthalmologist with expertise in connective tissue disorders. Careful and aggressive refraction and visual correction is mandatory in young children at risk for amblyopia.</p></div><div id="loeys-dietz.Other_1"><h4>Other</h4><p>Dural ectasia is usually asymptomatic. No effective therapies for symptomatic dural ectasia currently exist.</p><p>Hernias tend to recur after surgical intervention. A supporting mesh can be used during surgical repair to minimize <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a>.</p><p>Optimal management of pneumothorax to prevent recurrence may require chemical or surgical pleurodesis or surgical removal of pulmonary blebs.</p><p>Counseling regarding other life-threatening manifestations including spontaneous rupture of the spleen and bowel and pregnancy-associated risks is recommended.</p></div></div><div id="loeys-dietz.Prevention_of_Secondary_Comp"><h3>Prevention of Secondary Complications</h3><p>Use of subacute bacterial endocarditis prophylaxis should be considered for individuals with connective tissue disorders and documented evidence of mitral and/or aortic regurgitation who are undergoing dental work or other procedures expected to contaminate the bloodstream with bacteria.</p><p>Because of a high risk of cervical spine instability, a flexion and extension x-ray of the cervical spine should be performed prior to intubation or any other procedure involving manipulation of the neck.</p></div><div id="loeys-dietz.Surveillance"><h3>Surveillance</h3><p>All individuals with LDS require echocardiography at frequent intervals to monitor the status of the ascending aorta. The frequency of MRA or CTA evaluations should be tailored to clinical findings.</p><p>Individuals with cervical spine instability and severe or progressive scoliosis should be followed by an orthopedist.</p></div><div id="loeys-dietz.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>The following should be avoided:</p><ul><li class="half_rhythm"><div class="half_rhythm">Contact sports, competitive sports, and isometric exercise</div><div class="half_rhythm">Note: Individuals can and should remain active with aerobic activities performed in moderation.</div></li><li class="half_rhythm"><div class="half_rhythm">Agents that stimulate the cardiovascular system including routine use of decongestants or triptans for migraine headache management</div></li><li class="half_rhythm"><div class="half_rhythm">Activities that cause joint injury or pain</div></li><li class="half_rhythm"><div class="half_rhythm">For individuals at risk for recurrent pneumothorax, breathing against a resistance (e.g., playing a brass instrument) or positive pressure ventilation (e.g., SCUBA diving)</div></li></ul></div><div id="loeys-dietz.Evaluation_of_Relatives_at_R"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those individuals who need regular cardiovascular screening to detect aortic aneurysms and initiate appropriate medical or surgical intervention.</p><p>Evaluations can include the following:</p><ul><li class="half_rhythm"><div>Molecular genetic testing if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known</div></li><li class="half_rhythm"><div>Signs of the disorder if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is not known. Echocardiography and extensive vascular imaging of relatives is indicated upon appreciation of any suspicious signs of LDS, and even in apparently unaffected individuals if findings are subtle in the index case.</div></li></ul><p>See <a href="#loeys-dietz.Related_Genetic_Counseling_I">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="loeys-dietz.Pregnancy_Management"><h3>Pregnancy Management</h3><p>Pregnancy can be dangerous for women with LDS. Complications include aortic dissection/rupture or uterine rupture during pregnancy or delivery, or aortic dissection/rupture in the immediate postpartum period. Increased frequency of aortic imaging is recommended, both during pregnancy and in the weeks following delivery. However, with appropriate supervision and high-risk obstetric management, women with Loeys-Dietz syndrome can tolerate pregnancy and delivery [<a class="bk_pop" href="#loeys-dietz.REF.gutman.2009.35">Gutman et al 2009</a>, <a class="bk_pop" href="#loeys-dietz.REF.frise.2017.21">Frise et al 2017</a>].</p></div><div id="loeys-dietz.Therapies_Under_Investigatio"><h3>Therapies Under Investigation</h3><p>Experimental evidence suggests that many manifestations of LDS relate to excess activation of and signaling by the growth factor TGF&#x003b2;.</p><p><b>Animal</b> trials have shown that TGF&#x003b2; antagonizing agents, such as angiotensin II receptor type 1 blockers (ARBs), can slow or prevent vascular manifestations of LDS [<a class="bk_pop" href="#loeys-dietz.REF.gallo.2014.448">Gallo et al 2014</a>]. ARBs also attenuate the biochemical abnormalities in the aortic wall of mouse models of LDS. The safety and efficacy of such interventions has not been addressed for persons with LDS in a clinical trial setting, but ARBs have proven safe and comparable or superior to beta blockers in treating other vascular connective tissue disorders such as <a href="/books/n/gene/marfan/">Marfan syndrome</a>.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for information on clinical studies for a wide range of diseases and conditions..</p></div></div><div id="loeys-dietz.Genetic_Counseling"><h2 id="_loeys-dietz_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="loeys-dietz.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Loeys-Dietz syndrome (LDS) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="loeys-dietz.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Approximately 25% of individuals diagnosed with LDS have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>Approximately 75% of probands with LDS have the disorder as the result of a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>If the <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>, <i>TGFBR1</i>, or <i>TGFBR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is known, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of both parents is indicated. If the pathogenic variant is unknown, it is appropriate to evaluate both parents for manifestations of LDS, including a comprehensive clinical examination.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent (both parental somatic and germline mosaicism have been reported in rare cases).</div></li><li class="half_rhythm"><div>The family history of some individuals diagnosed with LDS may appear to be negative because of failure to recognize the disorder in family members, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, early death of the parent before the onset of symptoms, or late onset of the disorder in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has been performed on the parents of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</div></li><li class="half_rhythm"><div>Note: If the parent is the individual in whom the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> first occurred, s/he may have <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> for the variant and may be mildly/minimally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of the proband depends on the genetic status of the proband's parents:</p><ul><li class="half_rhythm"><div>If a parent of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, the risk to the sibs is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>The sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with clinically unaffected parents are still at increased risk for LDS because of the possibility of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in a parent.</div></li><li class="half_rhythm"><div>If the <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>, <i>TGFBR1</i>, or <i>TGFBR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with LDS has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>, <i>TGFBR1</i>, and <i>TGFBR2</i> pathogenic variants is reported to be near 100%; thus, offspring who inherit a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from a parent will have LDS, although the severity cannot be predicted.</div></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the status of the proband's parents: if a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, his or her family members may be at risk.</p></div><div id="loeys-dietz.Related_Genetic_Counseling_I"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#loeys-dietz.Evaluation_of_Relatives_at_R">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a></b>. When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with LDS has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="loeys-dietz.Prenatal_Testing_and_Preimpl"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> If the <i>SMAD2</i>, <i>SMAD3</i>, <i>TGFB2</i>, <i>TGFB3</i>, <i>TGFBR1</i>, or <i>TGFBR2</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> are possible.</p><p><b>Ultrasound examination</b> in the first two trimesters is insensitive in detecting manifestations of LDS, but prenatal occurrence of aortic dilatation has been described.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="loeys-dietz.Resources"><h2 id="_loeys-dietz_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=Loeys-Dietz%20syndrome&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz syndrome</a></div></li><li class="half_rhythm"><div><b>American Heart Association (AHA)</b></div><div>7272 Greenville Avenue</div><div>Dallas TX 75231</div><div><b>Phone:</b> 800-242-8721 (toll-free)</div><div><b>Email:</b> review.personal.info@heart.org</div><div><a href="http://www.heart.org/HEARTORG/Conditions/More/Types-of-Aneurysms_UCM_454436_Article.jsp" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Types of Aneurysms</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000162.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Abdominal aortic aneurysm</a></div></li><li class="half_rhythm"><div><b>National Marfan Foundation (NMF)</b></div><div><i>The National Marfan Foundation provides education and support for other heritable connective tissue disorders that share some features of Marfan syndrome.</i></div><div>22 Manhasset Avenue</div><div>Port Washington NY 11050</div><div><b>Phone:</b> 800-862-7326 (toll-free); 516-883-8712</div><div><b>Fax:</b> 516-883-8040</div><div><b>Email:</b> staff@marfan.org</div><div><a href="http://www.marfan.org/loeys-dietz" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz Syndrome</a></div></li></ul></div><div id="loeys-dietz.Molecular_Genetics"><h2 id="_loeys-dietz_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="loeys-dietz.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Loeys-Dietz Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_loeys-dietz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_loeys-dietz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_loeys-dietz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_loeys-dietz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_loeys-dietz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_loeys-dietz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4087" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SMAD2</i></a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4087" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">18q21<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q15796" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mothers against decapentaplegic homolog 2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://143.169.238.105/LOVD/genes/SMAD2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz Syndrome Mutation Database - SMAD2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SMAD2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SMAD2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD2</a></td></tr><tr><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/4088" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>SMAD3</i></a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=4088" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">15q22<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P84022" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Mothers against decapentaplegic homolog 3</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://143.169.238.105/LOVD/genes/SMAD3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz Syndrome Mutation Database - SMAD3</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=SMAD3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD3</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=SMAD3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">SMAD3</a></td></tr><tr><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7042" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TGFB2</i></a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7042" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">1q41</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P61812" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transforming growth factor beta-2 proprotein</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://143.169.238.105/LOVD/genes/TGFB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz Syndrome Mutation Database - TGFB2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TGFB2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFB2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TGFB2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFB2</a></td></tr><tr><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7043" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TGFB3</i></a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7043" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">14q24<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P10600" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Transforming growth factor beta-3 proprotein</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.arvcdatabase.info/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ARVD/C Genetic Variants Database (TGFB3)</a><br /><a href="http://143.169.238.105/LOVD/genes/TGFB3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz Syndrome Mutation Database - TGFB3</a><br /><a href="https://databases.lovd.nl/shared/genes/TGFB3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFB3 @ LOVD</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TGFB3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFB3</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TGFB3[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFB3</a></td></tr><tr><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7046" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TGFBR1</i></a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7046" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">9q22<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P36897" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGF-beta receptor type-1</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://143.169.238.105/LOVD/genes/tgfbr1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz Syndrome Mutation Database - TGFBR1</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TGFBR1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFBR1</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TGFBR1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFBR1</a></td></tr><tr><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7048" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>TGFBR2</i></a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7048" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">3p24<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P37173" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGF-beta receptor type-2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://143.169.238.105/LOVD/genes/tgfbr2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Loeys-Dietz Syndrome Mutation Database - TGFBR2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=TGFBR2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFBR2</a></td><td headers="hd_b_loeys-dietz.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=TGFBR2[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">TGFBR2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="loeys-dietz.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="loeys-dietz.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Loeys-Dietz Syndrome (<a href="/omim/190181,190182,190220,190230,601366,603109,609192,610168,613795,614816,615582" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1133/table/loeys-dietz.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__loeys-dietz.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/190181" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">190181</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE I; TGFBR1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/190182" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">190182</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFORMING GROWTH FACTOR-BETA RECEPTOR, TYPE II; TGFBR2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/190220" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">190220</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFORMING GROWTH FACTOR, BETA-2; TGFB2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/190230" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">190230</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">TRANSFORMING GROWTH FACTOR, BETA-3; TGFB3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/601366" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">601366</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 2; SMAD2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603109" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603109</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 3; SMAD3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609192" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609192</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOEYS-DIETZ SYNDROME 1; LDS1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/610168" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">610168</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOEYS-DIETZ SYNDROME 2; LDS2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613795" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613795</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOEYS-DIETZ SYNDROME 3; LDS3</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/614816" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">614816</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOEYS-DIETZ SYNDROME 4; LDS4</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/615582" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">615582</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LOEYS-DIETZ SYNDROME 5; LDS5</td></tr></tbody></table></div></div><div id="loeys-dietz.Molecular_Genetic_Pathogenes"><h3>Molecular Genetic Pathogenesis</h3><p>In the initial description of <i>TGFBR2</i> pathogenic variants causing a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> similar to Marfan syndrome [<a class="bk_pop" href="#loeys-dietz.REF.mizuguchi.2004.855">Mizuguchi et al 2004</a>] it was observed that recombinantly expressed mutated receptors in cells that were na&#x000ef;ve for TGF&#x003b2; receptors could not support TGF&#x003b2; signaling. Furthermore, there was no apparent <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> interference on the function of coexpressed wild type receptor. These data were interpreted to indicate <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a> and consequent reduced TGF&#x003b2; signaling as the relevant pathogenic mechanisms.</p><p>In keeping with this hypothesis, one of the original individuals with a Marfan syndrome-like <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> was shown to harbor a <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> breakpoint within <i>TGFBR2</i>. Complicating this hypothesis, however, is the observation of a distinct paucity of pathogenic <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or frameshift variants in either of the TGF&#x003b2; receptor genes in persons with LDS or related phenotypes. The mutated receptor subunits may not traffic to the cell surface or may not cycle, resulting in "functional <a class="def" href="/books/n/gene/glossary/def-item/haploinsufficiency/">haploinsufficiency</a>." The only reported nonsense variant occurs at the very distal margin of the penultimate <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>. As opposed to more proximal pathogenic nonsense variants, this context is not predicted to induce nonsense-mediated <a class="def" href="/books/n/gene/glossary/def-item/mrna/">mRNA</a> decay and clearance of the mutated transcripts. As a result, most (if not all) pathogenic variants in the TGF&#x003b2; receptor genes associated with vascular phenotypes are predicted to give rise to a mutated receptor protein that has the ability to traffic to the cell surface and bind extracellular ligand, but that specifically lacks the ability to propagate the intracellular TGF&#x003b2; signal. This hypothesis is also consistent with the finding that pathogenic variants cluster in the intracellular part of both <i>TGFBR1</i> and <i>TGFBR2</i> (serine-threonine kinase domains), with few pathogenic variants described in the extracellular <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>. However, a model that singularly invokes decreased TGF&#x003b2; signaling would be difficult to reconcile with the substantial evidence that many aspects of Marfan syndrome, including those that overlap with LDS, are caused by too much TGF&#x003b2; signaling and can be attenuated or prevented by TGF&#x003b2; antagonism in animal models.</p><p>Experiments exploring TGF&#x003b2; signaling in cells that only express mutated receptors may not be informative for the situation in vivo when <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for these pathogenic variants. Diminished but not absent function of TGF&#x003b2; receptors may initiate chronic and dysregulated compensatory mechanisms that result in too much TGF&#x003b2; signaling. Indeed, the study of fibroblasts derived from heterozygous individuals with LDS failed to reveal any defect in the acute phase response to administered ligand and showed an apparent increase in TGF&#x003b2; signaling after 24 hours of ligand deprivation and a slower decline in the TGF&#x003b2; signal after restoration of ligand. An even more informative result was the observation of increased nuclear accumulation of pSmad2 in the aortic wall of persons with either Marfan syndrome or LDS, and increased expression of TGF&#x003b2;-dependent <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> products such as collagen and CTGF. Taken together, these data demonstrate increased TGF&#x003b2; signaling in the vasculature of persons with LDS and in a context that is directly relevant to tissue development and homeostasis in vivo. Although the basis for this observation remains incompletely understood, it also seems possible that dysregulation of signaling requires the cell surface expression of receptors that can bind TGF&#x003b2; ligands, but that cannot propagate signal because of a deficiency in kinase function. In support of this hypothesis, it was shown that transgenic expression of a mutated, kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a>-deleted form of T&#x003b2;RII leads to increased TGF&#x003b2; signaling, including stimulation of the intracellular signaling cascade and increased output of TGF&#x003b2;-responsive genes, clearly suggesting a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism for mutated TGF&#x003b2; receptors in LDS.</p><div id="loeys-dietz.SMAD2"><h4><i>SMAD2</i></h4><p><b>Gene structure.</b>
<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_001003652.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001003652.3</a> represents the longest transcript (11 exons, 10 coding) and encodes the longest isoform, <a href="https://www.ncbi.nlm.nih.gov/protein/NP_001003652.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001003652.1</a>. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1133/#loeys-dietz.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The currently known pathogenic variants in <i>SMAD2</i> are predicted to lead to loss of function because they affect the functionally important MH2 <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> [<a class="bk_pop" href="#loeys-dietz.REF.micha.2015.1145">Micha et al 2015</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The reference sequence <a href="https://www.ncbi.nlm.nih.gov/protein/NP_001003652.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001003652.1</a> has 467 amino acids. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions as a transcriptional modulator activated by transforming growth factor-beta (provided by RefSeq, Apr 2009).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> No functional studies have been reported to date.</p></div><div id="loeys-dietz.SMAD3"><h4><i>SMAD3</i></h4><p><b>Gene structure.</b>
<a href="/nuccore/NM_005902.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_005902.3</a> represents the longest transcript (9 exons) and encodes the longest isoform of 425 AA (<a href="/protein/NP_005893.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005893.1</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1133/#loeys-dietz.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> Most variants in <i>SMAD3</i> are predicted to lead to loss of function. This is supported by the fact that about half of the currently reported pathogenic variants lead to <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> or out-of-frame frameshift variants [<a class="bk_pop" href="#loeys-dietz.REF.wischmeijer.2013.1028">Wischmeijer et al 2013</a>]</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The reference sequence <a href="/protein/NP_005893.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_005893.1</a> has 425 amino acids.</p><p>SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein functions as a transcriptional modulator activated by transforming growth factor-beta (provided by RefSeq, Apr 2009).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Despite the predicted <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> nature of most <i>SMAD3</i> pathogenic variants, a paradoxic gain of function on the overall TGF&#x003b2; signaling pathway in aortic walls of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals has been observed [<a class="bk_pop" href="#loeys-dietz.REF.van_de_laar.2011.121">van de Laar et al 2011</a>].</p></div><div id="loeys-dietz.TGFB2"><h4><i>TGFB2</i></h4><p><b>Gene structure.</b>
<i>TGFB2</i> consists of eight exons (<a href="/nuccore/NM_001135599.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001135599.2</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1133/#loeys-dietz.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> As with <i>SMAD3</i>, loss of function is the predicted mechanism that leads to disease. This hypothesis is supported by the observation of whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants, and pathogenic variants affecting critical sites for the activation of the TGFB2 cytokine from its latent state [<a class="bk_pop" href="#loeys-dietz.REF.lindsay.2012.922">Lindsay et al 2012</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The reference sequence <a href="/nuccore/NM_001135599.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001135599.2</a> has 442 amino acids. TGFB2 belongs to the superfamily of TGFB ligands and has three <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>: TGFB1, TGFB2, and TGFB3. The TGF-&#x003b2; family comprises three cytokines that regulate multiple aspects of cellular behavior, including proliferation, differentiation, migration, and specification of synthetic repertoire. Postnatally, TGF-&#x003b2; activity is most closely linked to wound healing, productive modulation of the immune system, and multiple pathologic processes including cancer progression and tissue fibrosis.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Similar to SMAD3, despite the predicted loss of function of TGFB2 protein, increased TGF&#x003b2; signaling was demonstrated in aortic walls of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who were <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TGFB2</i> [<a class="bk_pop" href="#loeys-dietz.REF.lindsay.2012.922">Lindsay et al 2012</a>].</p></div><div id="loeys-dietz.TGFB3"><h4><i>TGFB3</i></h4><p><b>Gene structure.</b> The longest transcript variant of <i>TGFB3</i> consists of seven exons (<a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003239.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003239.4</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1133/#loeys-dietz.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> As with <i>TGFB2</i>, loss of function is the predicted mechanism that leads to disease. This hypothesis is supported by the observation of <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> and out-of-frame <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants, and pathogenic variants affecting critical sites for the activation of the TGFB3 cytokine from its latent state [<a class="bk_pop" href="#loeys-dietz.REF.bertoliavella.2015.1324">Bertoli-Avella et al 2015</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The reference sequence <a href="https://www.ncbi.nlm.nih.gov/nuccore/NM_003239.4" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003239.4</a> encodes a protein of 412 amino acids (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_003230.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003230.1</a>). TGFB3 belongs to the superfamily of TGFB ligands and has three <a class="def" href="/books/n/gene/glossary/def-item/isoforms/">isoforms</a>: TGFB1, TGFB2, and TGFB3. The TGF-&#x003b2; family comprises three cytokines that regulate multiple aspects of cellular behavior including proliferation, differentiation, migration, and specification of synthetic repertoire. Postnatally, TGF-&#x003b2; activity is most closely linked to wound healing, productive modulation of the immune system, and multiple pathologic processes including cancer progression and tissue fibrosis.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Similar to TGFB2, despite the predicted loss of function of TGFB3 protein, increased TGF&#x003b2; signaling was demonstrated in aortic walls of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals who were <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>TGFB3</i> [<a class="bk_pop" href="#loeys-dietz.REF.bertoliavella.2015.1324">Bertoli-Avella et al 2015</a>].</p></div><div id="loeys-dietz.TGFBR1"><h4><i>TGFBR1</i></h4><p><b>Gene structure.</b>
<i>TGFBR1</i> (also referred to as activin receptor like kinase 5, or ALK-5) consists of nine exons. For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1133/#loeys-dietz.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Benign variants in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of <i>TGFBR1</i> are uncommon except for the polymorphic repeats encoding polyalanine in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 1 (reference sequence <a href="/nuccore/NM_004612.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_004612.2</a>).</p><p><b>Pathogenic variants.</b> The large majority of pathogenic variants identified so far are located in the exons coding for the intracellular serine-threonine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of both receptors. They most commonly involve pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; only a few <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants have been described.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TGFBR1</i> encodes a protein of 503 amino acids (reference sequence <a href="/protein/NP_004603.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_004603.1</a>). TGF&#x003b2; binds to three subtypes of cell surface receptors, known as the receptors type I, II, and III. Type I and II receptors are both serine/threonine kinase receptors that differ by the presence in type I of a glycine/serine-rich juxta-membrane <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> (GS domain), which is critical for its activation. Upon binding of the ligand to the constitutively active type II receptor, T&#x003b2;RI is recruited and transphosphorylated in the GS domain, thereby stimulating its protein kinase activity. The activated type I receptor propagates the signal inside the cell through phosphorylation of receptor-regulated SMADS (R-SMADS), SMAD2, or SMAD3. Activated or phosphorylated R-SMADS form heteromeric complexes with SMAD4 that translocate to the nucleus, where they control gene expression.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> See <a href="#loeys-dietz.Molecular_Genetic_Pathogenes">Molecular Genetic Pathogenesis</a>.</p></div><div id="loeys-dietz.TGFBR2"><h4><i>TGFBR2</i></h4><p><b>Gene structure.</b>
<i>TGFBR2</i> consists of seven exons (<a href="/nuccore/NM_001024847.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001024847.2</a>). For a detailed summary of <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> and protein information, see <a href="/books/NBK1133/#loeys-dietz.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Pathogenic variants.</b> The large majority of pathogenic variants identified so far are located in the exons coding for the intracellular serine-threonine kinase <a class="def" href="/books/n/gene/glossary/def-item/domain/">domain</a> of both receptors. They most commonly involve pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants; only a few <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants have been described.</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b>
<i>TGFBR2</i> encodes a protein of 567 amino acids (<a href="/protein/NP_001020018.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001020018.1</a>).</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> See <a href="#loeys-dietz.Molecular_Genetic_Pathogenes">Molecular Genetic Pathogenesis</a>.</p></div></div></div><div id="loeys-dietz.References"><h2 id="_loeys-dietz_References_">References</h2><div id="loeys-dietz.Published_Guidelines__Consen"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.maccarrick.2014">MacCarrick G, Black JH 3rd, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL, Sponseller PD, Loeys B, Dietz HC 3rd. Loeys-Dietz syndrome: a primer for diagnosis and management. Available <a href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131122/" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2014. Accessed 2-23-18.</div></li></ul></div><div id="loeys-dietz.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.attias.2009.2541">Attias D, Stheneur C, Roy C, Collod-B&#x000e9;roud G, Detaint D, Faivre L, Delrue MA, Cohen L, Francannet C, B&#x000e9;roud C, Claustres M, Iserin F, Khau Van Kien P, Lacombe D, Le Merrer M, Lyonnet S, Odent S, Plauchu H, Rio M, Rossi A, Sidi D, Steg PG, Ravaud P, Boileau C, Jondeau G. Comparison of clinical presentations and outcomes between patients with TGFBR2 and FBN1 mutations in Marfan syndrome and related disorders. <span><span class="ref-journal">Circulation. </span>2009;<span class="ref-vol">120</span>:2541–9.</span> [<a href="/pubmed/19996017" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19996017</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.barbier.2014.736">Barbier M, Gross MS, Aubart M, Hanna N, Kessler K, Guo DC, Tosolini L, Ho-Tin-Noe B, Regalado E, Varret M, Abifadel M, Milleron O, Odent S, Dupuis-Girod S, Faivre L, Edouard T, Dulac Y, Busa T, Gouya L, Milewicz DM, Jondeau G, Boileau C. MFAP5 loss-of-function mutations underscore the involvement of matrix alteration in the pathogenesis of familial thoracic aortic aneurysms and dissections. <span><span class="ref-journal">Am J Hum Genet. </span>2014;<span class="ref-vol">95</span>:736–43.</span> [<a href="/pmc/articles/PMC4259978/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4259978</span></a>] [<a href="/pubmed/25434006" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25434006</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.bertoliavella.2015.1324">Bertoli-Avella AM, Gillis E, Morisaki H, Verhagen JMA, de Graaf BM, van de Beek G, Gallo E, Kruithof BPT, Venselaar H, Myers LA, Laga S, Doyle AJ, Oswald G, van Cappellen GWA, Yamanaka I, van der Helm RM, Beverloo B, de Klein A, Pardo L, Lammens M, Evers C, Devriendt K, Dumoulein M, Timmermans J, Bruggenwirth HT, Verheijen F, Rodrigus I, Baynam G, Kempers M, Saenen J, Van Craenenbroeck EM, Minatoya K, Matsukawa R, Tsukube T, Kubo N, Hofstra R, Goumans MJ, Bekkers JA, Roos-Hesselink JW, van de Laar IMBH, Dietz HC, Van Laer L, Morisaki T, Wessels MW, Loeys BL. Mutations in a TGF-&#x003b2; ligand, TGFB3, cause syndromic aortic aneurysms and dissections. <span><span class="ref-journal">J Am Coll Cardiol. </span>2015;<span class="ref-vol">65</span>:1324–36.</span> [<a href="/pmc/articles/PMC4380321/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4380321</span></a>] [<a href="/pubmed/25835445" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25835445</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.boileau.2012.916">Boileau C, Guo DC, Hanna N, Regalado ES, Detaint D, Gong L, Varret M, Prakash SK, Li AH, d'Indy H, Braverman AC, Grandchamp B, Kwartler CS, Gouya L, Santos-Cortez RL, Abifadel M, Leal SM, Muti C, Shendure J, Gross MS, Rieder MJ, Vahanian A, Nickerson DA, Michel JB. National Heart, Lung, and Blood Institute (NHLBI) Go Exome Sequencing Project, Jondeau G, Milewicz DM. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:916–21.</span> [<a href="/pmc/articles/PMC4033668/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4033668</span></a>] [<a href="/pubmed/22772371" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22772371</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.breckpot.2010.408">Breckpot J, Budts W, De Zegher F, Vermeesch JR, Devriendt K. Duplication of the TGFBR1 gene causes features of Loeys-Dietz syndrome. <span><span class="ref-journal">Eur J Med Genet. </span>2010;<span class="ref-vol">53</span>:408–10.</span> [<a href="/pubmed/20813212" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20813212</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.campbell.2011.1442">Campbell IM, Kolodziejska KE, Quach MM, Wolf VL, Cheung SW, Lalani SR, Ramocki MB, Stankiewicz P. TGFBR2 deletion in a 20-month-old female with developmental delay and microcephaly. <span><span class="ref-journal">Am J Med Genet A. </span>2011;<span class="ref-vol">155A</span>:1442–7.</span> [<a href="/pmc/articles/PMC3646644/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3646644</span></a>] [<a href="/pubmed/21567932" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21567932</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.carmignac.2012.950">Carmignac V, Thevenon J, Ad&#x000e8;s L, Callewaert B, Julia S, Thauvin-Robinet C, Gueneau L, Courcet JB, Lopez E, Holman K, Renard M, Plauchu H, Plessis G, De Backer J, Child A, Arno G, Duplomb L, Callier P, Aral B, Vabres P, Gigot N, Arbustini E, Grasso M, Robinson PN, Goizet C, Baumann C, Di Rocco M, Sanchez Del Pozo J, Huet F, Jondeau G, Collod-Beroud G, Beroud C, Amiel J, Cormier-Daire V, Rivi&#x000e8;re JB, Boileau C, De Paepe A, Faivre L. In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">91</span>:950–7.</span> [<a href="/pmc/articles/PMC3487125/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3487125</span></a>] [<a href="/pubmed/23103230" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23103230</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.coady.1999.361">Coady MA, Davies RR, Roberts M, Goldstein LJ, Rogalski MJ, Rizzo JA, Hammond GL, Kopf GS, Elefteriades JA. Familial patterns of thoracic aortic aneurysms. <span><span class="ref-journal">Arch Surg. </span>1999;<span class="ref-vol">134</span>:361–7.</span> [<a href="/pubmed/10199307" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10199307</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.coucke.2006.452">Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A. Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tortuosity syndrome. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:452–7.</span> [<a href="/pubmed/16550171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16550171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.disabella.2011.321">Disabella E, Grasso M, Gambarin FI, Narula N, Dore R, Favalli V, Serio A, Antoniazzi E, Mosconi M, Pasotti M, Odero A, Arbustini E. Risk of dissection in thoracic aneurysms associated with mutations of smooth muscle alpha-actin 2 (ACTA2). <span><span class="ref-journal">Heart. </span>2011;<span class="ref-vol">97</span>:321–6.</span> [<a href="/pubmed/21212136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21212136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.doyle.2012.1249">Doyle AJ, Doyle JJ, Bessling SL, Maragh S, Lindsay ME, Schepers D, Gillis E, Mortier G, Homfray T, Sauls K, Norris RA, Huso ND, Leahy D, Mohr DW, Caulfield MJ, Scott AF, Destr&#x000e9;e A, Hennekam RC, Arn PH, Curry CJ, Van Laer L, McCallion AS, Loeys BL, Dietz HC. Mutations in the TGF-&#x003b2; repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:1249–54.</span> [<a href="/pmc/articles/PMC3545695/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3545695</span></a>] [<a href="/pubmed/23023332" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23023332</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.erkula.2010.1876">Erkula G, Sponseller PD, Paulsen LC, Oswald GL, Loeys BL, Dietz HC. Musculoskeletal findings of Loeys-Dietz syndrome. <span><span class="ref-journal">J Bone Joint Surg Am. </span>2010;<span class="ref-vol">92</span>:1876–83.</span> [<a href="/pubmed/20686062" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20686062</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.felgentreff.2014.43">Felgentreff K, Siepe M, Kotthoff S, von Kodolitsch Y, Schachtrup K, Notarangelo LD, Walter JE, Ehl S. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders. <span><span class="ref-journal">Clin Immunol. </span>2014;<span class="ref-vol">150</span>:43–50.</span> [<a href="/pubmed/24333532" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24333532</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.frischmeyerguerrerio.2013.195ra94">Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G, Chichester K, Myers L, Halushka MK, Oliva-Hemker M, Wood RA, Dietz HC. TGF&#x003b2; receptor mutations impose a strong predisposition for human allergic disease. <span><span class="ref-journal">Sci Transl Med. </span>2013;<span class="ref-vol">5</span>:195ra94.</span> [<a href="/pmc/articles/PMC3905327/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3905327</span></a>] [<a href="/pubmed/23884466" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23884466</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.frise.2017.21">Frise CJ, Pitcher A, Mackillop L. Loeys-Dietz syndrome and pregnancy: the first ten years. <span><span class="ref-journal">Int J Cardiol. </span>2017;<span class="ref-vol">226</span>:21–5.</span> [<a href="/pubmed/27780078" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27780078</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.gallo.2014.448">Gallo EM, Loch DC, Habashi JP, Calderon JF, Chen Y, Bedja D, van Erp C, Gerber EE, Parker SJ, Sauls K, Judge DP, Cooke SK, Lindsay ME, Rouf R, Myers L, ap Rhys CM, Kent KC, Norris RA, Huso DL, Dietz HC. Angiotensin II-dependent TGF-&#x003b2; signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. <span><span class="ref-journal">J Clin Invest. </span>2014;<span class="ref-vol">124</span>:448–60.</span> [<a href="/pmc/articles/PMC3871227/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3871227</span></a>] [<a href="/pubmed/24355923" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24355923</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.gaspar.2017.2289">Gaspar H, Lutz B, Reicherter K, L&#x000fc;hl S, Taurman R, Gabriel H, Brenner RE, Borck G. 4.7&#x02009;Mb deletion encompassing TGFB2 associated with features of Loeys-Dietz syndrome and osteoporosis in adulthood. <span><span class="ref-journal">Am J Med Genet A. </span>2017;<span class="ref-vol">173</span>:2289–92.</span> [<a href="/pubmed/28544325" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28544325</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.gillis.2017.400">Gillis E, Kumar AA, Luyckx I, Preuss C, Cannaerts E, van de Beek G, Wieschendorf B, Alaerts M, Bolar N, Vandeweyer G, Meester J, W&#x000fc;nnemann F, Gould RA, Zhurayev R, Zerbino D, Mohamed SA, Mital S, Mertens L, Bj&#x000f6;rck HM, Franco-Cereceda A, McCallion AS, Van Laer L, Verhagen JMA, van de Laar IMBH, Wessels MW, Messas E, Goudot G, Nemcikova M, Krebsova A, Kempers M, Salemink S, Duijnhouwer T, Jeunemaitre X, Albuisson J, Eriksson P, Andelfinger G, Dietz HC, Verstraeten A, Loeys BL, et al.  Candidate gene resequencing in a large bicuspid aortic valve-associated thoracic aortic aneurysm aohort: SMAD6 as an important contributor. <span><span class="ref-journal">Front Physiol. </span>2017;<span class="ref-vol">8</span>:400.</span> [<a href="/pmc/articles/PMC5469151/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5469151</span></a>] [<a href="/pubmed/28659821" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28659821</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.glancy.2001">Glancy DL, Wegmann M, Dhurandhar RW. Aortic dissection and patent ductus arteriosus in three generations. Am J Cardiol. 2001;87:813-5.A9. [<a href="/pubmed/11249915" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11249915</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.goudie.2011.365">Goudie DR, D'Alessandro M, Merriman B, Lee H, Szever&#x000e9;nyi I, Avery S, O'Connor BD, Nelson SF, Coats SE, Stewart A, Christie L, Pichert G, Friedel J, Hayes I, Burrows N, Whittaker S, Gerdes AM, Broesby-Olsen S, Ferguson-Smith MA, Verma C, Lunny DP, Reversade B, Lane EB. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:365–9.</span> [<a href="/pubmed/21358634" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21358634</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.guo.2015.170">Guo DC, Gong L, Regalado ES, Santos-Cortez RL, Zhao R, Cai B, Veeraraghavan S, Prakash SK, Johnson RJ, Muilenburg A, Willing M, Jondeau G, Boileau C, Pannu H, Moran R, Debacker J. GenTAC Investigators, National Heart, Lung, and Blood Institute Go Exome Sequencing Project, Montalcino Aortic Consortium, Bamshad MJ, Shendure J, Nickerson DA, Leal SM, Raman CS, Swindell EC, Milewicz DM. MAT2A mutations predispose individuals to thoracic aortic aneurysms. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">96</span>:170–7.</span> [<a href="/pmc/articles/PMC4289682/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4289682</span></a>] [<a href="/pubmed/25557781" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25557781</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.guo.2001.2461">Guo D, Hasham S, Kuang SQ, Vaughan CJ, Boerwinkle E, Chen H, Abuelo D, Dietz HC, Basson CT, Shete SS, Milewicz DM. Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. <span><span class="ref-journal">Circulation. </span>2001;<span class="ref-vol">103</span>:2461–8.</span> [<a href="/pubmed/11369686" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11369686</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.guo.2007.1488">Guo DC, Pannu H, Tran-Fadulu V, Papke CL, Yu RK, Avidan N, Bourgeois S, Estrera AL, Safi HJ, Sparks E, Amor D, Ades L, McConnell V, Willoughby CE, Abuelo D, Willing M, Lewis RA, Kim DH, Scherer S, Tung PP, Ahn C, Buja LM, Raman CS, Shete SS, Milewicz DM. Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1488–93.</span> [<a href="/pubmed/17994018" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17994018</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.guo.2013.398">Guo DC, Regalado E, Casteel DE, Santos-Cortez RL, Gong L, Kim JJ, Dyack S, Horne SG, Chang G, Jondeau G, Boileau C, Coselli JS, Li Z, Leal SM, Shendure J, Rieder MJ, Bamshad MJ, Nickerson DA. GenTAC Registry Consortium, National Heart, Lung, and Blood Institute Grand Opportunity Exome Sequencing Project, Kim C, Milewicz DM. Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections. <span><span class="ref-journal">Am J Hum Genet. </span>2013;<span class="ref-vol">93</span>:398–404.</span> [<a href="/pmc/articles/PMC3738837/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3738837</span></a>] [<a href="/pubmed/23910461" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23910461</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.guo.2016.928">Guo DC, Regalado ES, Gong L, Duan X, Santos-Cortez RL, Arnaud P, Ren Z, Cai B, Hostetler EM, Moran R, Liang D, Estrera A, Safi HJ. University of Washington Center for Mendelian Genomics, Leal SM, Bamshad MJ, Shendure J, Nickerson DA, Jondeau G, Boileau C, Milewicz DM. LOX mutations predispose to thoracic aortic aneurysms and dissections. <span><span class="ref-journal">Circ Res. </span>2016;<span class="ref-vol">118</span>:928–34.</span> [<a href="/pmc/articles/PMC4839295/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4839295</span></a>] [<a href="/pubmed/26838787" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26838787</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.gupta.2002.39">Gupta PA, Putnam EA, Carmical SG, Kaitila I, Steinmann B, Child A, Danesino C, Metcalfe K, Berry SA, Chen E, Delorme CV, Thong MK, Ades LC, Milewicz DM. Ten novel FBN2 mutations in congenital contractural arachnodactyly: delineation of the molecular pathogenesis and clinical phenotype. <span><span class="ref-journal">Hum Mutat. </span>2002;<span class="ref-vol">19</span>:39–48.</span> [<a href="/pubmed/11754102" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11754102</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.gutman.2009.35">Gutman G, Baris HN, Hirsch R, Mandel D, Yaron Y, Lessing JB, Kuperminc MJ. Loeys-Dietz syndrome in pregnancy: a case description and report of a novel mutation. <span><span class="ref-journal">Fetal Diagn Ther. </span>2009;<span class="ref-vol">26</span>:35–7.</span> [<a href="/pubmed/19816028" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19816028</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.hilhorsthofstee.2013.337">Hilhorst-Hofstee Y, Scholte AJ, Rijlaarsdam ME, van Haeringen A, Kroft LJ, Reijnierse M, Ruivenkamp CA, Versteegh MI, Pals G, Breuning MH. An unanticipated copy number variant of chromosome 15 disrupting SMAD3 reveals a three-generation family at serious risk for aortic dissection. <span><span class="ref-journal">Clin Genet. </span>2013;<span class="ref-vol">83</span>:337–44.</span> [<a href="/pubmed/22803640" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22803640</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.hoffjan.2011.520">Hoffjan S, Waldm&#x000fc;ller S, Blankenfeldt W, K&#x000f6;tting J, Gehle P, Binner P, Epplen JT, Scheffold T. Three novel mutations in the ACTA2 gene in German patients with thoracic aortic aneurysms and dissections. <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:520–4.</span> [<a href="/pmc/articles/PMC3083620/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3083620</span></a>] [<a href="/pubmed/21248741" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21248741</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.jondeau.2016.548">Jondeau G, Ropers J, Regalado E, Braverman A, Evangelista A, Teixedo G, De Backer J, Mui&#x000f1;o-Mosquera L, Naudion S, Zordan C, Morisaki T, Morisaki H, Von Kodolitsch Y, Dupuis-Girod S, Morris SA, Jeremy R, Odent S, Ad&#x000e8;s LC, Bakshi M, Holman K, LeMaire S, Milleron O, Langeois M, Spentchian M, Aubart M, Boileau C, Pyeritz R, Milewicz DM., Montalcino Aortic Consortium.  International registry of patients carrying TGFBR1 or TGFBR2 mutations: results of the MAC (Montalcino Aortic Consortium). <span><span class="ref-journal">Circ Cardiovasc Genet. </span>2016;<span class="ref-vol">9</span>:548–58.</span> [<a href="/pmc/articles/PMC5177493/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5177493</span></a>] [<a href="/pubmed/27879313" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27879313</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.judge.2005.1965">Judge DP, Dietz HC. Marfan's syndrome. <span><span class="ref-journal">Lancet. </span>2005;<span class="ref-vol">366</span>:1965–76.</span> [<a href="/pmc/articles/PMC1513064/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1513064</span></a>] [<a href="/pubmed/16325700" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16325700</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.khau_van_kien.2005.200">Khau Van Kien P, Mathieu F, Zhu L, Lalande A, Betard C, Lathrop M, Brunotte F, Wolf JE, Jeunemaitre X. Mapping of familial thoracic aortic aneurysm/dissection with patent ductus arteriosus to 16p12.2-p13.13. <span><span class="ref-journal">Circulation. </span>2005;<span class="ref-vol">112</span>:200–6.</span> [<a href="/pubmed/15998682" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15998682</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.khau_van_kien.2004.173">Khau Van Kien P, Wolf JE, Mathieu F, Zhu L, Salve N, Lalande A, Bonnet C, Lesca G, Plauchu H, Dellinger A, Nivelon-Chevallier A, Brunotte F, Jeunemaitre X. Familial thoracic aortic aneurysm/dissection with patent ductus arteriosus: genetic arguments for a particular pathophysiological entity. <span><span class="ref-journal">Eur J Hum Genet. </span>2004;<span class="ref-vol">12</span>:173–80.</span> [<a href="/pubmed/14722581" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14722581</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.kiando.2016.e100636">Kiando SR, Tucker NR, Castro-Vega LJ, Katz A, D'Escamard V, Tr&#x000e9;ard C, Fraher D, Albuisson J, Kadian-Dodov D, Ye Z, Austin E, Yang ML, Hunker K, Barlassina C, Cusi D, Galan P, Empana JP, Jouven X, Gimenez-Roqueplo AP, Bruneval P, Hyun Kim ES, Olin JW, Gornik HL, Azizi M, Plouin PF, Ellinor PT, Kullo IJ, Milan DJ, Ganesh SK, Boutouyrie P, Kovacic JC, Jeunemaitre X, Bouatia-Naji N. PHACTR1 is a genetic susceptibility locus for fibromuscular dysplasia supporting its complex genetic pattern of inheritance. <span><span class="ref-journal">PLoS Genet. </span>2016;<span class="ref-vol">12</span>:e100636.</span> [<a href="/pmc/articles/PMC5085032/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5085032</span></a>] [<a href="/pubmed/27792790" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27792790</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.kirmani.2010.1016">Kirmani S, Tebben PJ, Lteif AN, Gordon D, Clarke BL, Hefferan TE, Yaszemski MJ, McGrann PS, Lindor NM, Ellison JW. Germline TGF-beta receptor mutations and skeletal fragility: a report on two patients with Loeys-Dietz syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:1016–9.</span> [<a href="/pubmed/20358619" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20358619</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.kosaki.2006.104">Kosaki K, Takahashi D, Udaka T, Kosaki R, Matsumoto M, Ibe S, Isobe T, Tanaka Y, Takahashi T. Molecular pathology of Shprintzen-Goldberg. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:104–8.</span> [<a href="/pubmed/16333834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16333834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.kuang.2016.948">Kuang SQ, Medina-Martinez O, Guo DC, Gong L, Regalado ES, Reynolds CL, Boileau C, Jondeau G, Prakash SK, Kwartler CS, Zhu LY, Peters AM, Duan XY, Bamshad MJ, Shendure J, Nickerson DA, Santos-Cortez RL, Dong X, Leal SM, Majesky MW, Swindell EC, Jamrich M, Milewicz DM. FOXE3 mutations predispose to thoracic aortic aneurysms and dissections. <span><span class="ref-journal">J Clin Invest. </span>2016;<span class="ref-vol">126</span>:948–61.</span> [<a href="/pmc/articles/PMC4767350/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4767350</span></a>] [<a href="/pubmed/26854927" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26854927</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.lindsay.2011.308">Lindsay ME, Dietz H. Lessons on the pathogenesis of aneurysm from heritable conditions. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">473</span>:308–16.</span> [<a href="/pmc/articles/PMC3622871/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3622871</span></a>] [<a href="/pubmed/21593863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21593863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.lindsay.2012.922">Lindsay ME, Schepers D, Bolar NA, Doyle JJ, Gallo E, Fert-Bober J, Kempers MJ, Fishman EK, Chen Y, Myers L, Bjeda D, Oswald G, Elias AF, Levy HP, Anderlid BM, Yang MH, Bongers EM, Timmermans J, Braverman AC, Canham N, Mortier GR, Brunner HG, Byers PH, Van Eyk J, Van Laer L, Dietz HC, Loeys BL. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. <span><span class="ref-journal">Nat Genet. </span>2012;<span class="ref-vol">44</span>:922–7.</span> [<a href="/pmc/articles/PMC3616632/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3616632</span></a>] [<a href="/pubmed/22772368" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22772368</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.loeys.2005.275">Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T, Meyers J, Leitch CC, Katsanis N, Sharifi N, Xu FL, Myers LA, Spevak PJ, Cameron DE, De Backer J, Hellemans J, Chen Y, Davis EC, Webb CL, Kress W, Coucke P, Rifkin DB, De Paepe AM, Dietz HC. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. <span><span class="ref-journal">Nat Genet. </span>2005;<span class="ref-vol">37</span>:275–81.</span> [<a href="/pubmed/15731757" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15731757</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.loeys.2006.788">Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H, De Backer JF, Oswald GL, Symoens S, Manouvrier S, Roberts AE, Faravelli F, Greco MA, Pyeritz RE, Milewicz DM, Coucke PJ, Cameron DE, Braverman AC, Byers PH, De Paepe AM, Dietz HC. Aneurysm syndromes caused by mutations in the TGF-beta receptor. <span><span class="ref-journal">N Engl J Med. </span>2006;<span class="ref-vol">355</span>:788–98.</span> [<a href="/pubmed/16928994" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16928994</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.loscalzo.2007.1960">Loscalzo ML, Goh DL, Loeys B, Kent KC, Spevak PJ, Dietz HC. Familial thoracic aortic dilation and bicommissural aortic valve: a prospective analysis of natural history and inheritance. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:1960–7.</span> [<a href="/pubmed/17676603" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17676603</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.luyckx.2017.444">Luyckx I, Proost D, Hendriks JMH, Saenen J, Van Craenenbroeck EM, Vermeulen T, Peeters N, Wuyts W, Rodrigus I, Verstraeten A, Van Laer L, Loeys BL. Two novel MYLK nonsense mutations causing thoracic aortic aneurysms/dissections in patients without apparent family history. <span><span class="ref-journal">Clin Genet. </span>2017;<span class="ref-vol">92</span>:444–6.</span> [<a href="/pubmed/28401540" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28401540</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.maccarrick.2014.576">MacCarrick G, Black JH 3rd, Bowdin S, El-Hamamsy I, Frischmeyer-Guerrerio PA, Guerrerio AL, Sponseller PD, Loeys B, Dietz HC 3rd. Loeys-Dietz syndrome: a primer for diagnosis and management. <span><span class="ref-journal">Genet Med. </span>2014;<span class="ref-vol">16</span>:576–87.</span> [<a href="/pmc/articles/PMC4131122/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4131122</span></a>] [<a href="/pubmed/24577266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24577266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.maleszewski.2009.194">Maleszewski JJ, Miller DV, Lu J, Dietz HC, Halushka MK. Histopathologic findings in ascending aortas from individuals with Loeys-Dietz syndrome (LDS). <span><span class="ref-journal">Am J Surg Pathol. </span>2009;<span class="ref-vol">33</span>:194–201.</span> [<a href="/pubmed/18852674" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18852674</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.malfait.2005.28">Malfait F, Coucke P, Symoens S, Loeys B, Nuytinck L, De Paepe A. The molecular basis of classic Ehlers-Danlos syndrome: a comprehensive study of biochemical and molecular findings in 48 unrelated patients. <span><span class="ref-journal">Hum Mutat. </span>2005;<span class="ref-vol">25</span>:28–37.</span> [<a href="/pubmed/15580559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15580559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.malfait.2007.387">Malfait F, Symoens S, De Backer J, Hermanns-Le T, Sakalihasan N, Lapiere CM, Coucke P, De Paepe A. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood. <span><span class="ref-journal">Hum Mutat. </span>2007;<span class="ref-vol">28</span>:387–95.</span> [<a href="/pubmed/17211858" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17211858</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.martin.2007.275">Martin LJ, Ramachandran V, Cripe LH, Hinton RB, Andelfinger G, Tabangin M, Shooner K, Keddache M, Benson DW. Evidence in favor of linkage to human chromosomal regions 18q, 5q and 13q for bicuspid aortic valve and associated cardiovascular malformations. <span><span class="ref-journal">Hum Genet. </span>2007;<span class="ref-vol">121</span>:275–84.</span> [<a href="/pubmed/17203300" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17203300</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.meester.2017.582">Meester JAN, Verstraeten A, Schepers D, Alaerts M, Van Laer L, Loeys BL. Differences in manifestations of Marfan syndrome, Ehlers-Danlos syndrome, and Loeys- Dietz syndrome. <span><span class="ref-journal">Ann Cardiothorac Surg. </span>2017;<span class="ref-vol">6</span>:582–94.</span> [<a href="/pmc/articles/PMC5721110/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5721110</span></a>] [<a href="/pubmed/29270370" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29270370</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.micha.2015.1145">Micha D, Guo DC, Hilhorst-Hofstee Y, van Kooten F, Atmaja D, Overwater E, Cayami FK, Regalado ES, van Uffelen R, Venselaar H, Faradz SM, Vriend G, Weiss MM, Sistermans EA, Maugeri A, Milewicz DM, Pals G, van Dijk FS. SMAD2 mutations are associated with arterial aneurysms and dissections. <span><span class="ref-journal">Hum Mutat. </span>2015;<span class="ref-vol">36</span>:1145–9.</span> [<a href="/pubmed/26247899" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26247899</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.mizuguchi.2004.855">Mizuguchi T, Collod-Beroud G, Akiyama T, Abifadel M, Harada N, Morisaki T, Allard D, Varret M, Claustres M, Morisaki H, Ihara M, Kinoshita A, Yoshiura K, Junien C, Kajii T, Jondeau G, Ohta T, Kishino T, Furukawa Y, Nakamura Y, Niikawa N, Boileau C, Matsumoto N. Heterozygous TGFBR2 mutations in Marfan syndrome. <span><span class="ref-journal">Nat Genet. </span>2004;<span class="ref-vol">36</span>:855–60.</span> [<a href="/pmc/articles/PMC2230615/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2230615</span></a>] [<a href="/pubmed/15235604" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15235604</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.morisaki.2009.1406">Morisaki H, Akutsu K, Ogino H, Kondo N, Yamanaka I, Tsutsumi Y, Yoshimuta T, Okajima T, Matsuda H, Minatoya K, Sasaki H, Tanaka H, Ishibashi-Ueda H, Morisaki T. Mutation of ACTA2 gene as an important cause of familial and nonfamilial nonsyndromatic thoracic aortic aneurysm and/or dissection (TAAD). <span><span class="ref-journal">Hum Mutat. </span>2009;<span class="ref-vol">30</span>:1406–11.</span> [<a href="/pubmed/19639654" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19639654</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.nistri.1999.19">Nistri S, Sorbo MD, Marin M, Palisi M, Scognamiglio R, Thiene G. Aortic root dilatation in young men with normally functioning bicuspid aortic valves. <span><span class="ref-journal">Heart. </span>1999;<span class="ref-vol">82</span>:19–22.</span> [<a href="/pmc/articles/PMC1729087/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1729087</span></a>] [<a href="/pubmed/10377302" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10377302</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.pannu.2007.2453">Pannu H, Tran-Fadulu V, Papke CL, Scherer S, Liu Y, Presley C, Guo D, Estrera AL, Safi HJ, Brasier AR, Vick GW, Marian AJ, Raman CS, Buja LM, Milewicz DM. MYH11 mutations result in a distinct vascular pathology driven by insulin-like growth factor 1 and angiotensin II. <span><span class="ref-journal">Hum Mol Genet. </span>2007;<span class="ref-vol">16</span>:2453–62.</span> [<a href="/pmc/articles/PMC2905218/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2905218</span></a>] [<a href="/pubmed/17666408" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17666408</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.redon.2006.759">Redon R, Baujat G, Sanlaville D, Le Merrer M, Vekemans M, Munnich A, Carter NP, Cormier-Daire V, Colleaux L. Interstitial 9q22.3 microdeletion: clinical and molecular characterisation of a newly recognised overgrowth syndrome. <span><span class="ref-journal">Eur J Hum Genet. </span>2006;<span class="ref-vol">14</span>:759–67.</span> [<a href="/pubmed/16570072" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16570072</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.renard.2013.314">Renard M, Callewaert B, Baetens M, Campens L, MacDermot K, Fryns JP, Bonduelle M, Dietz HC, Gaspar IM, Cavaco D, Stattin EL, Schrander-Stumpel C, Coucke P, Loeys B, De Paepe A, De Backer J. Novel MYH11 and ACTA2 mutations reveal a role for enhanced TGF&#x003b2; signaling in FTAAD. <span><span class="ref-journal">Int J Cardiol. </span>2013;<span class="ref-vol">165</span>:314–21.</span> [<a href="/pmc/articles/PMC3253210/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3253210</span></a>] [<a href="/pubmed/21937134" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21937134</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.robinson.2006.109">Robinson P, Neumann L, Tinschert S. Response to Kosaki et al, Molecular Pathology of Shprintzen-Goldberg. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:109–10.</span> [<a href="/pubmed/16333834" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16333834</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.roman.1989.507">Roman MJ, Devereux RB, Kramer-Fox R, O'Loughlin J. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. <span><span class="ref-journal">Am J Cardiol. </span>1989;<span class="ref-vol">64</span>:507–12.</span> [<a href="/pubmed/2773795" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2773795</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.schwarze.2004.917">Schwarze U, Hata RI, McKusick VA, Shinkai H, Hoyme HE, Pyeritz RE, Byers PH. Rare autosomal recessive cardiac valvular form of Ehlers-Danlos syndrome results from mutations in the COL1A2 gene that activate the nonsense-mediated RNA decay pathway. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:917–30.</span> [<a href="/pmc/articles/PMC1181985/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181985</span></a>] [<a href="/pubmed/15077201" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15077201</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.van_de_laar.2011.121">van de Laar IM, Oldenburg RA, Pals G, Roos-Hesselink JW, de Graaf BM, Verhagen JM, Hoedemaekers YM, Willemsen R, Severijnen LA, Venselaar H, Vriend G, Pattynama PM, Coll&#x000e9;e M, Majoor-Krakauer D, Poldermans D, Frohn-Mulder IM, Micha D, Timmermans J, Hilhorst-Hofstee Y, Bierma-Zeinstra SM, Willems PJ, Kros JM, Oei EH, Oostra BA, Wessels MW, Bertoli-Avella AM. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:121–6.</span> [<a href="/pubmed/21217753" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21217753</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.van_hemelrijk.2010.546">Van Hemelrijk C, Renard M, Loeys B. The Loeys-Dietz syndrome: an update for the clinician. <span><span class="ref-journal">Curr Opin Cardiol. </span>2010;<span class="ref-vol">25</span>:546–51.</span> [<a href="/pubmed/20838339" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20838339</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.vaughan.2001.2469">Vaughan CJ, Casey M, He J, Veugelers M, Henderson K, Guo D, Campagna R, Roman MJ, Milewicz DM, Devereux RB, Basson CT. Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder. <span><span class="ref-journal">Circulation. </span>2001;<span class="ref-vol">103</span>:2469–75.</span> [<a href="/pubmed/11369687" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11369687</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.wang.2010.701">Wang L, Guo DC, Cao J, Gong L, Kamm KE, Regalado E, Li L, Shete S, He WQ, Zhu MS, Offermanns S, Gilchrist D, Elefteriades J, Stull JT, Milewicz DM. Mutations in myosin light chain kinase cause familial aortic dissections. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:701–7.</span> [<a href="/pmc/articles/PMC2978973/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2978973</span></a>] [<a href="/pubmed/21055718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21055718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.wenstrup.2002.112">Wenstrup RJ, Meyer RA, Lyle JS, Hoechstetter L, Rose PS, Levy HP, Francomano CA. Prevalence of aortic root dilation in the Ehlers-Danlos syndrome. <span><span class="ref-journal">Genet Med. </span>2002;<span class="ref-vol">4</span>:112–7.</span> [<a href="/pubmed/12180144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12180144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.wessels.2004.134">Wessels MW, Catsman-Berrevoets CE, Mancini GM, Breuning MH, Hoogeboom JJ, Stroink H, Frohn-Mulder I, Coucke PJ, Paepe AD, Niermeijer MF, Willems PJ. Three new families with arterial tortuosity syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2004;<span class="ref-vol">131</span>:134–43.</span> [<a href="/pubmed/15529317" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15529317</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.wischmeijer.2013.1028">Wischmeijer A, Van Laer L, Tortora G, Bolar NA, Van Camp G, Fransen E, Peeters N, di Bartolomeo R, Pacini D, Gargiulo G, Turci S, Bonvicini M, Mariucci E, Lovato L, Brusori S, Ritelli M, Colombi M, Garavelli L, Seri M, Loeys BL. Thoracic aortic aneurysm in infancy in aneurysms-osteoarthritis syndrome due to a novel SMAD3 mutation: further delineation of the phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2013;<span class="ref-vol">161A</span>:1028–35.</span> [<a href="/pubmed/23554019" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23554019</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.yetman.2007.e1199">Yetman AT, Beroukhim RS, Ivy DD, Manchester D. Importance of the clinical recognition of Loeys-Dietz syndrome in the neonatal period. <span><span class="ref-journal">Pediatrics. </span>2007;<span class="ref-vol">119</span>:e1199–202.</span> [<a href="/pmc/articles/PMC3131201/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3131201</span></a>] [<a href="/pubmed/17470566" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17470566</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.zaidi.2013.220">Zaidi S, Choi M, Wakimoto H, Ma L, Jiang J, Overton JD, Romano-Adesman A, Bjornson RD, Breitbart RE, Brown KK, Carriero NJ, Cheung YH, Deanfield J, DePalma S, Fakhro KA, Glessner J, Hakonarson H, Italia MJ, Kaltman JR, Kaski J, Kim R, Kline JK, Lee T, Leipzig J, Lopez A, Mane SM, Mitchell LE, Newburger JW, Parfenov M, Pe'er I, Porter G, Roberts AE, Sachidanandam R, Sanders SJ, Seiden HS, State MW, Subramanian S, Tikhonova IR, Wang W, Warburton D, White PS, Williams IA, Zhao H, Seidman JG, Brueckner M, Chung WK, Gelb BD, Goldmuntz E, Seidman CE, Lifton RP. De novo mutations in histone-modifying genes in congenital heart disease. <span><span class="ref-journal">Nature. </span>2013;<span class="ref-vol">498</span>:220–3.</span> [<a href="/pmc/articles/PMC3706629/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3706629</span></a>] [<a href="/pubmed/23665959" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23665959</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.zhu.2006.343">Zhu L, Vranckx R, Khau Van Kien P, Lalande A, Boisset N, Mathieu F, Wegman M, Glancy L, Gasc JM, Brunotte F, Bruneval P, Wolf JE, Michel JB, Jeunemaitre X. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:343–9.</span> [<a href="/pubmed/16444274" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16444274</span></a>]</div></li></ul></div><div id="loeys-dietz.Suggested_Reading"><h3>Suggested Reading</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.akutsu.2007.1305">Akutsu K, Morisaki H, Takeshita S, Sakamoto S, Tamori Y, Yoshimuta T, Yokoyama N, Nonogi H, Ogino H, Morisaki T. Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-beta receptor genes. <span><span class="ref-journal">Circ J. </span>2007;<span class="ref-vol">71</span>:1305–9.</span> [<a href="/pubmed/17652900" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17652900</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.johnson.2007.w2935">Johnson PT, Chen JK, Loeys BL, Dietz HC, Fishman EK. Loeys-Dietz syndrome: MDCT angiography findings. <span><span class="ref-journal">AJR Am J Roentgenol. </span>2007;<span class="ref-vol">189</span>:W29-35.</span> [<a href="/pubmed/17579132" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17579132</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.ki.2005.561">Ki CS, Jin DK, Chang SH, Kim JE, Kim JW, Park BK, Choi JH, Park IS, Yoo HW. Identification of a novel TGFBR2 gene mutation in a Korean patient with Loeys-Dietz aortic aneurysm syndrome; no mutation in TGFBR2 gene in 30 patients with classic Marfan's syndrome. <span><span class="ref-journal">Clin Genet. </span>2005;<span class="ref-vol">68</span>:561–3.</span> [<a href="/pubmed/16283890" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16283890</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.lemaire.2007.167">LeMaire SA, Pannu H, Tran-Fadulu V, Carter SA, Coselli JS, Milewicz DM. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. <span><span class="ref-journal">Nat Clin Pract Cardiovasc Med. </span>2007;<span class="ref-vol">4</span>:167–71.</span> [<a href="/pmc/articles/PMC2561071/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2561071</span></a>] [<a href="/pubmed/17330129" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17330129</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.m_ty_s.2006.760">M&#x000e1;ty&#x000e1;s G, Arnold E, Carrel T, Baumgartner D, Boileau C, Berger W, Steinmann B. Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome-related disorders. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:760–9.</span> [<a href="/pubmed/16791849" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16791849</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.mizuguchi.2007.1">Mizuguchi T, Matsumoto N. Recent progress in genetics of Marfan syndrome and Marfan-associated disorders. <span><span class="ref-journal">J Hum Genet. </span>2007;<span class="ref-vol">52</span>:1–12.</span> [<a href="/pubmed/17061023" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17061023</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.sakai.2006.1719">Sakai H, Visser R, Ikegawa S, Ito E, Numabe H, Watanabe Y, Mikami H, Kondoh T, Kitoh H, Sugiyama R, Okamoto N, Ogata T, Fodde R, Mizuno S, Takamura K, Egashira M, Sasaki N, Watanabe S, Nishimaki S, Takada F, Nagai T, Okada Y, Aoka Y, Yasuda K, Iwasa M, Kogaki S, Harada N, Mizuguchi T, Matsumoto N. Comprehensive genetic analysis of relevant four genes in 49 patients with Marfan syndrome or Marfan-related phenotypes. <span><span class="ref-journal">Am J Med Genet A. </span>2006;<span class="ref-vol">140</span>:1719–25.</span> [<a href="/pubmed/16835936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16835936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.singh.2006.770">Singh KK, Rommel K, Mishra A, Karck M, Haverich A, Schmidtke J, Arslan-Kirchner M. TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. <span><span class="ref-journal">Hum Mutat. </span>2006;<span class="ref-vol">27</span>:770–7.</span> [<a href="/pubmed/16799921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16799921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="loeys-dietz.REF.williams.2007.s757">Williams JA, Loeys BL, Nwakanma LU, Dietz HC, Spevak PJ, Patel ND, Francois K, DeBacker J, Gott VL, Vricella LA, Cameron DE. Early surgical experience with Loeys-Dietz: a new syndrome of aggressive thoracic aortic aneurysm disease. <span><span class="ref-journal">Ann Thorac Surg. </span>2007;<span class="ref-vol">83</span>:S757–63.</span> [<a href="/pubmed/17257922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17257922</span></a>]</div></li></ul></div></div><div id="loeys-dietz.Chapter_Notes"><h2 id="_loeys-dietz_Chapter_Notes_">Chapter Notes</h2><div id="loeys-dietz.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>1 March 2018 (ma) Comprehensive update posted live</div></li><li class="half_rhythm"><div>11 July 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>29 April 2008 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing for <i>TGFBR1</i> available clinically</div></li><li class="half_rhythm"><div>28 February 2008 (me) Review posted live</div></li><li class="half_rhythm"><div>2 July 2007 (bl) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1133</span><span class="label">PMID: <a href="/pubmed/20301312" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301312</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lipoid-p/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/rws/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1133&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1133/?report=reader">PubReader</a></li><li><a href="/books/NBK1133/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1133" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1133" style="display:none" title="Cite this Page"><div class="bk_tt">Loeys BL, Dietz HC. Loeys-Dietz Syndrome. 2008 Feb 28 [Updated 2018 Mar 1]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1133/pdf/Bookshelf_NBK1133.pdf">PDF version of this page</a> (595K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#loeys-dietz.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#loeys-dietz.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#loeys-dietz.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#loeys-dietz.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#loeys-dietz.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#loeys-dietz.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#loeys-dietz.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#loeys-dietz.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#loeys-dietz.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#loeys-dietz.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=4088[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">SMAD3</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7046[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TGFBR1</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7042[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TGFB2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7048[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TGFBR2</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7043[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">TGFB3</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1489208" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1489208" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1489208" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1489208" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301510" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Marfan Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Dietz H. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/25392904" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Arterial Tortuosity Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Arterial Tortuosity Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Callewaert B, De Paepe A, Coucke P. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301454" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shprintzen-Goldberg Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Shprintzen-Goldberg Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Greally MT. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31145570" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Apert Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Wenger TL, Hing AV, Evans KN. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301667" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vascular Ehlers-Danlos Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Vascular Ehlers-Danlos Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Byers PH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301312" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301312" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040f3739a66ee2ba7bef08">Loeys-Dietz Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Loeys-Dietz Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:39:03-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C1179E0407E51000000000316010C&amp;ncbi_session=CE8C1179E040F371_0790SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1133%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1133&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1133/&amp;ncbi_pagename=Loeys-Dietz Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C1179E040F371_0790SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>